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Abstract 
Determination of testosterone and related compounds in body fluids is of utmost 
importance in doping control and the diagnosis of many diseases. Capillary 
electromigration techniques are a relatively new approach for steroid research. 
Owing to their electrical neutrality, however, separation of steroids by capillary 
electromigration techniques requires the use of charged electrolyte additives that 
interact with the steroids either specifically or non-specifically. The analysis of 
testosterone and related steroids by non-specific micellar electrokinetic 
chromatography (MEKC) was investigated in this study. The partial filling (PF) 
technique was employed, being suitable for detection by both ultraviolet 
spectrophotometry (UV) and electrospray ionization mass spectrometry (ESI-MS). 
Efficient, quantitative PF-MEKCUV methods for steroid standards were 
developed through the use of optimized pseudostationary phases comprising 
surfactants and cyclodextrins. PF-MEKCUV proved to be a more sensitive, 
efficient and repeatable method for the steroids than PF-MEKCESI-MS. We 
discovered that in PF-MEKC analyses of electrically neutral steroids, ESI-MS 
interfacing sets significant limitations not only on the chemistry affecting the 
ionization and detection processes, but also on the separation. The new PF-MEKCUV 
method was successfully employed in the determination of testosterone in male 
urine samples after microscale immunoaffinity solid-phase extraction (IA-SPE). 
The IA-SPE method, relying on specific interactions between testosterone and a 
recombinant anti-testosterone Fab fragment, is the first such method described 
for testosterone. Finally, new data for interactions between steroids and human 
and bovine serum albumins were obtained through the use of affinity capillary 
electrophoresis. A new algorithm for the calculation of association constants 
between proteins and neutral ligands is introduced. 
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Tiivistelmä 
Testosteronin ja sen sukuisten steroidien määrittäminen kehon nesteistä on 
keskeistä doping-valvonnassa sekä monien sairauksien diagnosoinnissa. Kapillaari-
elektromigraatiotekniikat ovat varsin uusi lähtökohta steroiditutkimuksille. 
Steroidien sähköisestä varauksettomuudesta johtuen kapillaarielektromigraatio-
tekniikoiden soveltaminen steroidien erottamiseen edellyttää ionisoituvien orgaa-
nisten lisäaineiden käyttöä elektrolyyttiliuoksessa. Lisäaineilla voi olla joko 
spesifisiä tai epäspesifisia vuorovaikutuksia steroidien kanssa. Tässä tutkimuksessa 
testosteronin ja sen sukuisten steroidien määrittämistä tutkittiin epäspesifisellä 
misellisellä sähkökineettisellä kromatografialla (MEKC). Osittaistäyttötekniikan 
(PF) ansiosta steroidit voitiin tunnistaa sekä ultraviolettispektrofotometrisesti 
(UV) että sähkösumutus-ionisaatiomassaspektrofotometrisesti (ESI-MS). Steroidi-
standardeille kehitettiin tehokkaat ja kvantitatiiviset PF-MEKCUV-menetelmät 
käyttäen lisäaineina tensidejä sekä syklodekstriinejä. PF-MEKCUV osoittautui 
herkemmäksi, tehokkaammaksi ja toistettavammaksi menetelmäksi kuin  
PF-MEKCESI-MS. Tutkimuksessa havaittiin, että ESI-MS-liitäntä asettaa 
huomattavia kemiallisia rajoituksia paitsi ionisaatio- ja detektointitapahtumille 
myös erotustapahtumalle. Uutta PF-MEKCUV-menetelmää voitiin käyttää 
testosteronin määrittämiseen miesten virtsanäytteistä miniatyrisoidun immuno-
affiniteettikiinteäfaasiuuton (IA-SPE) jälkeen. Kyseinen IA-SPE perustuu vuoro-
vaikutuksiin testosteronin ja sille spesifisen rekombinantin Fab-fragmentin 
välillä. Aikaisemmin IA-SPE:tä ei ole sovellettu testosteronin uuttamiseen. Lopuksi, 
uutta tietoa steroidien sekä ihmisen ja naudan seerumin albumiinin välisistä vuoro-
vaikutuksista saatiin affiniteettikapillaarielektroforeesin avulla. Tutkimuksessa 
kehitettiin uusi algoritmi, jonka avulla voidaan laskea proteiinien ja neutraalien 
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The first capillary electromigration technique, capillary electrophoresis (CE), 
was introduced by Jorgenson and Lukacs in 1981 [1], and quickly became 
established as a tool for clinical, pharmaceutical, and bioanalytical studies. 
Today it is in routine use in laboratories worldwide. CE is an efficient technique 
for separating compounds according to their differences in charge, mass, and 
three-dimensional structure. The separation is typically performed in a narrow 
(i.d. 20100 µm) silica capillary [2], filled with an electrolyte solution. Separation 
occurs when an electric field is applied across the capillary. Innumerable ionized 
compounds have been separated by CE, ranging from small inorganic ions to 
proteins and other large biomolecules. 
Electrically neutral compounds, including many steroid hormones, cannot be 
separated in an electric field unless they are interacting with charged electrolyte 
additives. Thus, CE is not a suitable separation technique for them. A common 
capillary electromigration technique for neutral analytes is micellar electrokinetic 
chromatography (MEKC), introduced by Terabe et al. in 1984 [3]. In MEKC, a 
surfactant, such as sodium dodecyl sulfate (SDS), is added to an aqueous 
electrolyte solution at concentrations higher than the critical micelle concentration 
(CMC). At such concentrations, and at temperatures higher than the Kraft point, 
the surfactants begin to form dynamic micelles, and when an electric field is 
applied the analytes are separated according to differences in their distribution 
between the highly charged micelles and the aqueous electrolyte solution. 
Besides their lack of charge, another challenge in the separation of steroids is 
their structural similarity. Related compounds often cannot be separated with a 
simple pseudostationary phase consisting of just one type of surfactant, such as 
SDS. Careful optimization of the separation process is required. Selectivity and 
resolution in MEKC can often be altered through use of mixed micellar solutions 
(comprising two or more types of surfactants) or additives, such as organic 
solvents and cyclodextrins. 
Reliable and fast determination of the principal androgen, testosterone, and 
related electrically neutral steroids in body fluids is of great importance in 
clinical laboratories and doping control. In the diagnosis of hypogonadism, 
polycystic ovary disease, and growth retardation [4], for instance, their 
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quantification in body fluids is of utmost importance. Most traditional and 
routine methods for the determination of testosterone and related steroids have 
demonstrated pitfalls. Problems are typically associated with the complexity of 
sample pretreatment or insufficient specificity. Despite the challenges due to 
neutrality and structural similarity, the use of capillary electromigration techniques 
in steroid determinations is highly attractive. Relative to many conventional 
methods, they have considerable advantages, as will be discussed below. 
In the first part of this study (IIV), efficient MEKC methods were developed 
for the separation of testosterone and related steroids. The compositions of the 
pseudostationary phases were carefully optimized. Through use of the partial 
filling technique (PF), the methods were designed to allow ultraviolet (UV) 
and/or electrospray ionization mass spectrometric (ESI-MS) detection. 
Further, the suitability of the new PF-MEKC methods for determination of 
testosterone in male urine samples was investigated (III). The sensitivity and 
specificity of the analysis were enhanced by immunoaffinity solid-phase extraction 
(IA-SPE), through use of a recombinant anti-testosterone antibody Fab fragment. 
Both in-capillary and off-line IA-SPE of testosterone were investigated. The in-
capillary analyses were an application of immunoaffinity capillary electrophoresis 
(IACE), a subtechnique of affinity capillary electrophoresis (ACE). ACE covers all 
those capillary electromigration techniques in which specific, often biospecific, 
interactions between electrolyte additives and analytes are employed [2]. Highly 
specific interactions between testosterone and the anti-testosterone Fab fragment 
were utilized in this part of the work (III). 
Finally (V), interactions between testosterone-related steroids and human and bovine 
serum albumins were investigated by partial filling affinity capillary electrophoresis 
(PF-ACE). The physiological role of some of the steroids, especially epitestosterone, 
has not yet been fully resolved, and the association constants for the binding of 
the steroids with albumins provide important new information for endocrinologists. 
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2. Review of the literature 
The literature review begins with a look at the theory behind the capillary 
electromigration techniques employed in this study. The analytes of interest, 
testosterone and its related compounds, are introduced, and traditional methods 
for their determination are reviewed, along with capillary electromigration 
techniques currently available for steroid research. Conventional non-specific 
sample pretreatment methods for steroid analysis are noted and, in particular, the 
use of antibodies (and antibody fragments) in analyte-specific solid-phase 
extraction is discussed. Finally, steroid identification by electrospray ionization 
mass spectrometry is described. 
2.1 Capillary electromigration techniques 
According to IUPAC (International Union of Pure and Applied Chemistry) [2], 
capillary electromigration techniques are divided as follows: capillary electrophoresis 
(also called capillary zone electrophoresis), capillary sieving electrophoresis, 
capillary gel electrophoresis, capillary isotachophoresis, capillary isoelectric 
focusing, electrokinetic chromatography, micellar electrokinetic chromatography, 
microemulsion electrokinetic chromatography, affinity capillary electrophoresis, 
and capillary electrochromatography. The four capillary electromigration techniques 
employed in this work are reviewed below. 
2.1.1 Capillary electrophoresis 
Separations in capillary electrophoresis (CE, CZE) are usually performed in a 
fused silica capillary. The inner wall of the capillary consists of silanol (Si-OH) 
groups, which become ionized in contact with a solution of pH above 2 [2, 5]. 
The negatively charged silanol groups give rise to an ion layer next to the wall, 
in which the population of positively charged counterions predominates [2]. The 
cation layer consists of a stable Stern layer and a diffuse layer. When an electric 
field is applied across the capillary, cations present in the diffuse layer start 
migrating toward the cathode, dragging the surrounding solvent molecules along 
[6]. The bulk movement of the solution relative to the stationary charged surface 
is referred to as electroosmotic flow (EOF) [6]. At distances greater than that of 
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the width of the Stern layer, where the electroosmotic flow is zero, the EOF 
increases rapidly towards the center of the capillary until, at distances greater 
than the thickness of the diffuse layer, it becomes essentially constant [2]. In CE, 
the diffuse layer is very thin (on the order of the Debye length, κ-1) [6] relative to 
the inner radius of the capillary. Thus, the EOF has a flat profile which, from the 
point of view of separation, is a notable advantage in comparison with the 
parabolic flow profiles occurring in pressure-driven techniques. 
The strength of the EOF is directly proportional to the zeta potential occurring 
between the Stern layer and the diffuse layer [6]. The pH value of the electrolyte 
solution determines the degree of dissociation of the silanol groups, which in 
turn affects the formation of the electric double layer. Thus, high alkality results 
in strong EOF [5]. The electroosmotic velocity, ν0, is expressed as [2] 
00 µυ E=  (1) 
where E is the electric field. 
In capillary electromigration this velocity is positive, by convention, in the 
direction from the sample introduction end to the detector end. In the reverse 
direction it is negative [2]. 






r−=  (2) 
where εr is the relative permittivity of the electrolyte solution (usually taken as that 
of the pure solvent), ε0 is the permittivity of vacuum, ζ is the zeta potential, and η the 
dynamic viscosity of the electrolyte solution (where the ratio of permittivity to 
viscosity is assumed to be independent of the electric field of the double layer). 






0 =µ  (3) 
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where Ldet is the the effective length of the capillary, Ltot the total length of the 
capillary, V the applied voltage, and teof the migration time of a neutral EOF marker. 
EOF is often also employed to force neutral and anionic analytes toward the 
cathode. In CE, neutral analytes migrate along with the EOF, whereas anions, 
having absolute electrophoretic mobilities toward the anode, migrate more 




LLdet=µ  (4) 
where ta is the migration time of the analyte. 
The total velocity, νtot, of an analyte is determined by its electrophoretic velocity, 
νep, and EOF [2]: 
0ννν += eptot  (5) 
Approximate resolution (R) between two adjacent analyte zones (i and j) can be 







,, −=  (6) 
where ta is the migration time of the analyte and σ the peak width (at base). 






,=α  (7) 
Identification of the analytes is typically performed close to the outlet end of the 
capillary (e.g. ultraviolet (UV) and laser induced fluorescence (LIF) detection), 
making the effective length of the capillary shorter than the total length. One 
important exception to this is mass spectrometric (MS) detection, in which the 
analytes are identified immediately after they exit the capillary. 
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CE is a suitable separation technique for a variety of analytes, ranging from 
small inorganic ions to large polymers and biomolecules. The only requirements 
for analytes are that they are soluble in appropriate solvents and, to be separated, 
they have to possess an electric charge. 
CE is not an effective separation technique for testosterone and its related 
compounds, which are electrically neutral under pH 1416 [9, 10]. Only a few 
capillary electromigration techniques provide resolution for neutral analytes. All 
have something in common: namely, they simultaneously combine the separation 
power of CE with non-specific or specific interactions between the analytes and 
charged electrolyte additives (mobile or immobilized) that hinder the migration 
of the neutral analytes with the electroosmotic flow. 
2.1.2 Micellar electrokinetic chromatography 
Micellar electrokinetic chromatography (MEKC) was introduced in 1984 by 
Terabe et al. [3] to solve the problem of separating neutral analytes in an electric 
field. MEKC relies on the use of surfactants which, above the critical micelle 
concentration (CMC) and the Kraft point (temperature at which the solubility of 
the surfactant is equal to its CMC [11]), aggregate to form dynamic micelle 
structures when dissolved in an aqueous electrolyte solution. Typically, the ionic 
and/or hydrophilic head groups of surfactants (e.g. sodium dodecyl sulfate, SDS) 
form the surface of the micelles, while the hydrophobic tails occupy the core. 
When an electric field is applied, the analytes are separated according to the 
differences in their partition between the bulk aqueous solvent and the micelles 
[12]. The separation process involves hydrophobic as well as other non-specific 










k ==  (8) 
where nmc and naq are the molar amounts of the analyte in the micellar and 
aqueous phases, respectively, K is the distribution constant and Vmc and Vaq are 
the corresponding volumes of the phases. 
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Since no solid stationary phase is employed, Terabe [3] describes MEKC as a 
type of liquidliquid partition chromatography. According to Khaledi [11], 
MEKC combines some of the features of reversed phase HPLC and CE. Because 
the dynamic aggregates possess an electrophoretic mobility in the capillary, the 
micellar solution is called a pseudostationary phase. Consequently, a limited 
elution window exists. In successful MEKC analyses, the analytes migrate 









Figure 1. A schematic MEKC electropherogram (performed at normal polarity). 
EOF is the marker of the electroosmotic flow; A1, A2, and A3 are electrically 
neutral analytes; and M is the hydrophobic marker of the frontline of the 
micellar phase, consisting of anionic surfactants. 
SDS is the most commonly used surfactant in MEKC [13]. Among its many 
appropriate features are high aqueous solubility, high aggregation number 62, 
relatively low CMC, and low UV absorptivity [11]. However, SDS micelles 
often fail to provide sufficient resolution between structurally similar compounds 
[1416]. Selectivity in MEKC can be altered by modifying the composition of 
the pseudostationary phase. Mixed micelles, consisting of two or more types of 
surfactants, such as SDS and bile salts, often provide better resolution between 
structurally related steroid compounds [17]. 
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Bile acids are compounds with a hydroxyl-substituted steroid backbone [14], 
which play an important role in lipid digestion and absorption, solubilization of 
cholesterol, and bile formation. According to Roda et al. [18], the number and 
orientation of hydroxyl groups in the bile acid structure determine its detergency 
(the higher the number of OH groups, the higher the CMC). Taurocholic acid, 
having three hydroxyl groups, possesses a CMC of 6 mM in 150 mM NaCl [18]. 
Unlike SDS, which forms large spherical micelles, bile salts form small, helical 
aggregates [14]. Bile salts are seldom employed as the only surfactants in 
MEKC, but rather to form mixed micelles. 
Wiedmer et al. [15] have shown that sodium cholate (SC) in low concentrations 
incorporates into SDS micelles so that the hydrophilic (ionic) groups face the 
aqueous solution. They have also confirmed that the micelles change little in size 
with increase in the amount of SC. In other words, low concentrations of cholate 
molecules are dissolved in the SDS micelles as hydrophobic analytes. Further, 
Wiedmer et al. found that in a solution containing SDS (above its CMC) and SC, 
a wide range of micelles exist with different SDS-to-SC ratios [15]. The 
diversity of SDS-SC micelles is beneficial in the separation of corticosteroids 
and androstenedione by MEKC [15, 19]. Notably, with the SDS concentration 
kept constant (18 mM) while the concentration of SC is increased from 0 to 
55 mM, the incorporation of corticosteroids and especially that of androstenedione 
in the SDS micelles is clearly diminished [15]. The authors explain this in terms 
of the competitive incorporation of SC and the steroids into the SDS micelles. 
Excellent resolution for corticosteroids has also been achieved with mixed micelles 
consisting of SDS and other bile salts, e.g. SDS / sodium taurocholate [16], 
SDS / sodium dehydrocholate [16], and SDS / taurocholate / glycodeoxycholate [14]. 
The MEKC applications for testosterone and closely related compounds are few 
by comparison [2023], and none of them relies on the use of mixed micelles. 
Exhaustive studies in this field are clearly desirable. 
MEKC can be employed in sample concentration by the sweeping effect. Capillary 
electromigration techniques typically suffer from low sensitivity owing to minute 
sample volumes and a limited optical path length (i.e. i.d. of the capillary), 
which means that in-capillary concentration is highly beneficial. Sweeping 
results when the pseudostationary phase, while penetrating the sample zone, 
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entraps and accumulates the analytes [24, 25]. The sample is prepared in a 
solution that is free from the pseudostationary phase and has conductivity similar 
to or higher than that of the background electrolyte (BGE) [25]. Effective sweeping 
can be achieved when the analytes interact markedly with the pseudostationary 
phase [26]. 
Theoretically, following the law of conservation of mass, the analyte concentration 
(Csweep) after sweeping is [24] 
)1( kCC injsweep +=  (9) 
where Cinj is the concentration of analyte in the injected sample zone and k is the 
retention factor. 
Usually, the effectiveness of sweeping is expressed as a sensitivity enhancement 
factor in terms of peak height (SEFheight) [27]. 
A higher sensitivity enhancement is achieved under acidic conditions (pH 23) 
than under neutral and alkaline conditions [28] owing to the attenuated EOF. A 
schematic view of sweeping of hydrophobic neutral steroids under neutral or 
alkaline conditions is presented in Figure 2. 
 
Figure 2. Sweeping of hydrophobic neutral steroids (T) with anionic surfactants 
(micelles) under neutral or alkaline conditions. A relatively large sample volume 
is injected from the anode side. The micelles, having absolute electrophoretic 
mobilities toward the anode, penetrate the sample zone, entrap and accumulate 









Through sweeping between 100- and 5000-fold [24, 30, 31] concentration of 
hydrophobic analytes has been achieved under acidic conditions. At reversed 
polarity, a 1500-fold concentration of testosterone was achieved by sweeping 
with 100 mM SDS in 100 mM phosphoric acid (pH 1.9) containing 20% ACN 
and 2% MeOH [24]. In another approach, a 330-fold concentration of T was 
achieved with a pseudostationary phase consisting of 20 mM SDS / 60 mM 
N-dodecyl-N,N-dimethylammonium-3-propane-1-sulfonic acid solution in 10 mM 
phosphate under neutral conditions (pH 7.0) [32]. 
Hitherto, sweeping has mostly been investigated and utilized in UV 
spectrophotometric detection [24, 3032] and LIF [33]. Rarely has it been 
applied with MS detection. Isoo et al. [28] demonstrated the use of sweeping in 
MEKC-APCI-MS analyses of cationic and uncharged compounds under acidic 
and neutral conditions. Under neutral conditions, about 100-fold increase in the 
concentration was achieved for aromatic amines, whereas under acidic conditions, 
100 to 600-fold sensitivity enhancement was obtained for amines and alkyl 
phthalates [28]. 
Partial filling micellar electrokinetic chromatography (PF-MEKC) was derived 
from micellar electrokinetic chromatography (MEKC) by Terabe et al. [34, 35] 
as a means to improve the performance of in-line mass spectrometric (MS) 
detection after the separation of neutral analytes by MEKC. The surfactants 
employed in MEKC are poorly compatible with MS detection, for many reasons. 
Nonvolatile surfactants easily contaminate the MS instrument. They tend to 
make the electrospray unstable [3638], and they often lower the sensitivity of 
the detection [35, 3941]. In PF-MEKC, only part of the capillary is filled with 
the micellar pseudostationary phase solution. Anionic surfactants, which are 
preferred in PF-MEKC, have a lower total velocity to the detector than do the 
analytes. When an electric field is applied, the analytes separate while passing 
through the micellar solution. However, after passing the plug of the 
pseudostationary phase, the analytes migrate in the background electrolyte along 
with the EOF, i.e. faster than the surfactants. The electric voltages are switched 
off immediately after identification of the analytes, and the capillary containing 
the surfactants is then rinsed before the next analysis [37]. 
The surfactant concentration and the micellar zone length are the main 
experimental parameters that can be varied to optimize resolution in PF-MEKC 
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[42]. The behavior of the injected micellar solution differs from that in 
traditional MEKC. In general, micelles possess a much higher effective mobility 
than the individual surfactant monomers because micelle formation leads to 
reduced viscosity. In PF-MEKC, micelles that migrate into the buffer at the rear 
side of the surfactant zone experience an aqueous phase without surfactant 
monomers. The total amount of micelles gradually decreases, and finally a 
steady state is reached where all surfactant molecules migrate as monomers. The 
time required to reach a steady state is proportional to the length and surfactant 
concentration of the injected micellar zone [42]. Since the amount of micelles 
decreases with time, compounds with a higher retention factor will experience a 
smaller effective separation length. One notable drawback of PF-MEKC-MS is 
that efficiencies tend to be lower than with normal MEKC [42]. 
It has been suggested that comparable migration times can be obtained by varying 
the micellar zone length and surfactant concentration in different ways [42]. In 
PF-MEKC, however, an additional band broadening occurs at the micellar zone-
buffer boundary due to the partial laminar flow, generated by the difference in 
the electric field strengths of the two zones [42]. Since this band broadening 
increases with higher retention factors, a low surfactant concentration is to be 
preferred. 
Since the first studies of PF-MEKC-MS [35, 43], several applications of the 
technique have been presented, many of them relying on electrospray ionization 
(ESI). Identifications by PF-MEKCESI-MS have been reported for corticosteroids 
[37], peptides [35], herbicides [43], pesticides [44], pharmaceuticals [39, 45, 46], 
iridoid glucosides in plant samples [47], and microbial signaling molecules 
(N-acyl-L-homoserine lactones) in microbial extracts [48]. The applications for 
human biomolecules are still few [35, 37], as well as those for real samples in 
general [47, 48]. 
2.1.3 Electrokinetic chromatography and cyclodextrin-modified 
micellar electrokinetic chromatography 
Electrokinetic chromatography (EKC) comprises capillary electromigration 
techniques in which additives are employed as components of a dispersed phase 
moving at a velocity different from the ν0 [2]. According to IUPAC, MEKC is a 
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special case of EKC [2]. Other useful additives, besides surfactants, especially 
for the separation of enantiomers, are cyclodextrins (CDs), including underivatized 
and natural CDs such as α-, β-, and γ-CDs, and various derivatized CDs [27]. 
CDs are widely utilized as additives in MEKC [27, 49, 50, 51]. For instance, 
Otsuka et al. [27] describe the enantiomeric separation of triadimenol with 
25 mM hydroxypropyl-γ-CD / 50 mM SDS in phosphate buffer (pH 7.0). They 
also investigated the sweeping effect under optimized conditions and found an 
approximately 10-fold increase in terms of the sensitivity enhancement factor 
measured as peak height (SEFheight). Recently, a brief report describing the 
separation and in-capillary concentration of corticosteroids by MEKC was 
published by Kartsova [52]. The sample was prepared in BGE (25 mM phosphate, 
pH 2.5) containing 5 mM of β-CD, and the pseudostationary phase consisted of 
20 mM SDS and 4.5 mM urea. When β-CDs were added to the sample matrix, 
SEFheight values between 20 and 200 were obtained as compared to samples 
without CDs. 
Only one study describes the separation of T and related structures by EKC and 
CD-modified MEKC. Urban et al. [22] investigated the determination of T, MT, 
and methandrostenolone with sodium taurodeoxycholate, neutral β-cyclodextrins 
(β-CDs), and/or anionic succinylated β-CDs as auxiliary components in 50 mM 
borate (pH 9.0). The best results were obtained with 10 mM succinylated β-CD 
and 1 mM β-CD in 50 mM borate not containing surfactants. Hitherto, no related 
reports exist. 
2.1.4 Affinity and immunoaffinity capillary electrophoresis 
According to IUPAC, affinity capillary electrophoresis (ACE) refers to those 
capillary electromigration techniques in which the BGE contains substances 
capable of specific interactions with the analytes [2]. Affinity interactions are 
often understood as selective binding between compounds at least one of which 
is a biopolymer (usually protein) [53]. The terminology for ACE has not yet 
been fully established. According to several authors [5456], in ACE and 
specifically in immunoaffinity capillary electrophoresis (IACE, discussed below), 




From the analytical point of view, dynamic ACE and MEKC have a number of 
features in common, the most important being the noncovalent interactions 
occurring between the analytes and the electrolyte additives during separation. 
However, the separation mechanisms are radically different. In ACE, the affinity 
interactions, which are often highly selective [53], occur between molecules, 
whereas in MEKC, the analytes are usually retained by dynamic micelles 
through non-specific electrostatic and hydrophobic interactions. 
Furthermore, except for a few competitive approaches [5759], ACE has only 
been performed with charged analytes, ranging from proteins to hydrophilic 
carbohydrates [60, 61] and a variety of drugs. MEKC, in contrast, is usually 
applied for electrically neutral analytes of moderate hydrophobicity, although 
separation of charged analytes is also possible. ACE is typically performed in 
mild electrolyte solutions such as ones that mimic body fluids, whereas MEKC, 
performed with high concentrations of surfactant(s), is a destructive method for 
highly organized three-dimensional structures. Finally, ACE is usually utilized 
in determination of binding between xenobiotics and biomolecules, though 
separations of drug enantiomers with the aid of auxiliary proteins have also been 
reported [6266]. In comparison with MEKC, ACE offers separations of much 
reduced resolution. 
ACE is a convenient technique for evaluating association constants between 
drugs and proteins [58, 6778]. In dynamic ACE, the equilibrium between free 
and protein-bound ligand (e.g. drug) is established in the capillary on the basis of 
electrostatic and hydrophobic interactions, reinforced by conformational 
compatibility. The kinetics of the interaction between a protein and ligand 
determines whether dynamic ACE can be used for evaluating association 
constants. If the interactions are very strong (irreversible in the CE separation 
time scale), nonequilibrium ACE can be employed, in which the sample 
containing both the protein and the ligand is pre-equilibrated, and the free and 
protein-bound ligand are then separated and quantified [79]. 
In the conventional dynamic approach, the ligand (e.g. a drug) is used as 
electrolyte additive and the protein as sample. However, this approach often has 
disadvantages as compared with the opposite approach, in which the capillary is 
filled with an electrolyte solution containing the protein in different concentrations, 
and a constant molar amount of ligand (drug) is introduced to the capillary. In 
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the latter case, after application of an electric field, the apparent mobility of the 
drug depends on the association (i.e. binding) constant, Kb, and the difference 
between the electrophoretic mobilities of the free and protein-bound drug. 
Variation in the concentration of the protein solution introduced to the capillary 
makes it possible to express the apparent mobility of the drug as a function of 
protein concentration, and to obtain a Scatchard plot with the assumption of an 
association stoichiometry of 1:1. 
The benefits of using the protein as the electrolyte additive and the ligand as the 
sample include smaller errors in the analyte migration time due to generally 
better peak shape, higher reproducibility of the ligand migration time, and a 
larger shift in the mobility of the analyte [79] when the concentration of the 
protein solution is altered. 
Unfortunately, when the capillary is completely filled with a protein solution, the 
sensitivity of UV detection is lost due to high background absorption. To prevent 
this problem, Valtceva et al. [80] introduced the partial filling technique, in which 
only a small plug of protein solution is introduced to the capillary. Tanaka and Terabe 
[62] were the first to apply the partial filling technique in ACE (PF-ACE). To 
date, several PF-ACE separations of chiral drugs [6266], including oxprenolol 
[66], bupivacaine [64], and propranolol [65], have been reported. PF-ACE has 
also been used in the determination of the association constants between α1-acid 
glycoprotein and propranolol, mepivacaine, and chlorpheniramine [76] and 
between carbonic anhydrase B and arylsulfonamides [59, 71]. 
ACE has many benefits over other methods used for the determination of 
association constants. In contrast to surface plasmon resonance (SPR) and 
HPLC, in ACE the proteins are present in mobile form and the protein 
immobilization and regeneration procedures are avoided. Sample consumption is 
low, concentrations of the interacting compounds in the capillary are easily 
controlled [54, 68, 74], and the reliability of the experimentally determined 
association constants is good [68]. Finally, the interactions between drugs and 
proteins occur without the sterical hindrances that may result from protein 
immobilization. In other words, the values obtained by ACE indeed reflect the 
equilibrium as it exists in solution [81]. Notably, however, problems may arise 
when ACE is applied to proteins that have a high molecular mass (> 100 kDa) or 
high pI (> 8.4) owing to electrostatic adsorption on the silica capillary [58, 82]. 
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Hitherto, if competitive approaches are excluded, a notable limitation of ACE 
has been the ability to study directly only the affinity between ionized compounds. 
Immunoaffinity capillary electrophoresis (IACE) refers to those ACE 
approaches that take advantage of interactions between antibody proteins and 
antigens. In IACE, the separation power of CE is combined with highly specific 
affinity interactions [56, 81, 8385]. The combination of immunochemistry and 
capillary electromigration techniques has attracted considerable attention, and 
today numerous IACE methods are available [55, 81, 85, 86]. IACE can be 
carried out in three formats [55], referred to below as iiii (Table 1). 
We recently reviewed the IACE procedures since 1998 for the analysis of body 
fluids and tissues for drugs, hormones and disease markers [86] and concluded 
that, to date, IACE format ii (Table 1) has been most widely employed. IACE 
format i was investigated in the present study, and special features of this format 
are discussed in the following. Readers with an interest in IACE in general are 
referred to Refs. [56], [81], and [86]. 
Table 1. Description of IACE formats.  
i Immobilizing antibody or antigen onto the inner wall of the capillary or onto a 
support material integrated in the separation path, and performing complexation 
during or before CE separation. 
ii Mixing of antibody and antigen in a vessel and allowing complexation to proceed 
to equilibrium before introducing the mixture to the CE capillary. 
iii Complexing free antigen with free antibody in the CE capillary. When the 

























Figure 3. Schematic representation of IACE (format i). The capillary inner wall 
is coated with antibodies or antibody fragments, such as Fabs. The IACE 
procedure comprises sample introduction, washing, elution of the analytes (a), 
separation and quantification. Modified from Ref. 83. 
Whenever IACE format i is employed, the orientation of the immobilized 
antibodies becomes of great concern [56]. Optimal antigen binding is achieved 
when the binding site of the antibody is oriented away from the capillary wall or 
other support material. Antibodies and immobilization procedures are further 
discussed in section 2.6. 
Few IACE analyses have been performed with immobilized antibodies (i) [83, 
84, 8792]. Pioneering work in the field was done by Guzman and Phillips. The 
first IACE studies describing the determination of urinary methamphetamine and 
urate [91] and serum IgE [92] with use of immobilized antibodies were 
performed by Guzman et al. 
In 1998 [83], Phillips presented an IACE method for the determination of some 
biologically important neuropeptides in human biopsy tissues. One-third of the 
silica capillary was coated with anti-neuropeptide antibody Fab fragments. 
After pretreatment of the tissues (including labeling of the neuropeptides), a 
 
33 
sample of 100 µL was injected into the immunoaffinity capillary and incubated 
for 5 min. The capillary was then rinsed and the analytes were eluted at low pH. 
The analytes were identified by LIF. Excellent recoveries (over 95%) were 
obtained. Shortly thereafter [87], a similar approach was introduced for the 
determination of recombinant cytokines in body fluids, such as plasma, serum 
(equivalent to blood plasma except that it lacks the plasma components that have 
taken part in the clotting process, mainly fibrinogen), urine, saliva and 
cerebrospinal fluid. 
Gonadotropin-releasing hormone (GnRH) in serum and urine specimens from a 
healthy person and from a patient suffering from benign prostatic hyperplasia was 
determined by Guzman [84], who used IACE coupled to a UV spectrophotometer 
and ESI-MS. GnRH present in the serum or urine was captured by immobilized 
monovalent Fab fragments covalently bound to controlled porous glass (CPG) 
beads in a microscale-format affinity chamber. The capillary containing the 
GnRH concentrator was prepared to fit into a commercial CE cartridge. The limit 
of quantification (LOQ) for GnRH in serum was 1 ng/mL with the IACE-UV 
technique. GnRH was also identified by CEESI-MS. 
A few years ago, Guzman [89] introduced a compact solid-phase microextraction 
device for use in IACE determinations of ibuprofen, naproxen, and the 
neuropeptides angiotensin II and neurotensin in spiked urine. Monomeric Fab 
fragments against the analytes were covalently immobilized on CPG beads via 
hinge-region cysteins that allowed optimal orientation. The beads were placed at 
a crossing and fixed with porous polymeric frits. In the horizontal position there 
was a tube for sample introduction and buffer washing (performed manually 
with a syringe), while in the vertical position, two fused-silica capillaries were 
connected to the crossing to perform CE. Diluted urine specimens were spiked 
with the drugs or neuropeptides (15 ng/mL), and the samples were analyzed in 
two separate microconcentrators. Identification of the separated analytes was 
performed by UV. The LOQs after spiking of the matrices were approximately 
1 ng/mL for ibuprofen and naproxen, and 0.5 ng/mL for the neuropeptides. 
Clinically relevant levels of the disease marker cardiac troponin I (cTnI) in 
serum were determined by Dalluge et al. [88], who used a short bed of 
monoclonal anti-cTnI-coated porous silica in a fused-silica capillary. The porous 
silica was first chemically modified with 3-aminopropyltriethoxysilane, dried, 
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and exposed to glutaric dialdehyde. Subsequently, anti-cTnI antibodies were 
randomly immobilized to glutaric dialdehyde via free amino groups. The 
immunoaffinity matrix was introduced into the capillary by pressure and held in 
the capillary by two frits. Detection was performed by UV. The method proved 
to be sensitive (LOD < 10 ng) and precise (RSD 34%). According to the group, 
the only limitation of the technique was the low flow rate through the capillary 
resulting in long sample injection times (~ 60 min). 
A common feature of the above-reviewed IACE (format i) applications is that 
they were developed for charged analytes. As of today, IACE applications 
(format i) for neutral analytes do not exist. 
In recent years, the focus in IACE has turned to micro- total analysis systems 
[9399]. In these applications, the whole procedure, including immunoaffinity 
extraction, optional labeling reactions, electrodriven separation, and 
identification, is performed on a microchip. Microchip technology and the 
phenomena affecting the movement of solutions and analytes in microfluidic 
devices differ from those of capillary electromigration techniques, but 
preliminary macroscale IACE studies may offer a valuable background for the 
microscale applications. 
2.2 Testosterone and related steroids 
The capillary elecromigration methods developed in this work were applied to 
the analysis of testosterone and related steroids. 
Andrew [100] classifies steroid hormones by their biological activity into 
androgens, estrogens, progestogens, corticosteroids, and mineralocorticoids. Our 
focus was on androgens, a group consisting of testosterone and related hormones 
and their synthetic derivatives. 
Testosterone (T) is the principal androgen, produced in men mainly by the testis 
and in women by the ovary and the adrenal gland [101]. Testosterone has both 
anabolic and androgenic effects in the human body. Anabolic effects stimulate 
nitrogen fixation and erythropoiesis, and increase protein synthesis (Figure 4) [4, 
102]. Testosterone is involved in prenatal androgenic sexual differentiation, 
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sexual maturation, and fertility throughout male life [102, 103]. It acts on a 
number of target tissues, including bone, skeletal and cardiac muscles, brain, 
liver, kidney, and adipocytes [4]. In recent investigations of the role of T in the 
development of metabolic syndrome and diabetes in men, it is proposed that low 
testosterone levels promote these metabolic disorders [104, 105]. 
Natural testosterone concentrations in plasma range from 835 nM in healthy 
adult males down to less than 2 nM in women and children [103, 106]. Only 
about 2% of T is free in plasma [107, 108]. Most T is conjugated with human 
serum albumin (HSA) (ranging from 50 [107] to 54% [108] in men, and from 20 
[107] to 30% [108] in women) and with sex hormone binding globulin (SHBG) 
(44% and 78% in men and women, respectively, as tested in Canadians) [108]. 
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Figure 4. Combined effect of androgens on the oxygen delivery system and muscle 
mass (myotrophic action). 2,3-Diphosphoglycerate decreases hemoglobinoxygen 
affinity. P50 = oxygen pressure at which 50% of hemoglobin is oxygen saturated 
under normal physiologic conditions. Modified from Ref 4. 
Binding of testosterone to HSA has been widely investigated [107, 110, 111114]. 
It is suggested that there is one primary binding site for T in the II domain of the 
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HSA structure [112, 113] and that the stoichiometric binding ratio is 1:1 [113]. 
Association constants (Kb) for T and HSA of (2.0 ± 0.2) ×104 M-1 (at pH 7.4, 
25 °C) [113], (2.8 ± 0.2) ×104 M-1 (at pH 7.4, 20 °C) [112] and (3.3 ± 0.3) ×104 M-1 
(at pH 7.4, 25 °C) [114] have been reported. Binding of T to HSA is affected by 
temperature, pH, and the presence of other plasma components, such as fatty 
acids [113, 114]. Interestingly, the affinity between T and bovine serum albumin 
(BSA) is slightly weaker than that between T and HSA [114]. 
Testosterone (Figure 5a) and related steroids have a hydrophobic tetracyclic 
perhydro-1,2-cyclopentanophenanthrene ring in their structure. T and many related 
steroids are largely metabolized in the human body before excretion in urine 
[101]. Enzymatically catalyzed phase-I reactions convert the steroids into more 
polar structures in order to inactivate them and facilitate their elimination from 
the body [101]. Phase II reactions act to couple the steroid or its metabolite with 
glucuronic acid or sulfate [101]. 3α-O-β-Glucuronides are the predominant 
metabolites of T and structurally similar compounds. A tiny fraction of testosterone 
is also excreted as sulfate conjugate [115, 116]. Normally, intact T is not found 
in urine [117]. After a successful deconjugation of glucuronide groups, the 
concentration of T in male urine is approximately 3060 µg/L [118, 119]. 
Androstenedione (A) (Figure 5b) is an endogenous immediate precursor of 
testosterone. In healthy men and fertile women, the clinical reference values in 
plasma vary from 3 to 7 and from 3 to 11 nM, respectively. The metabolism of 
orally administered androstenedione and urinary excretion of androstenedione 
and testosterone metabolites have been investigated [120]. It was concluded that 
the administration of androstenedione increases the excretion rate of conjugated 










































Figure 5. Structures of investigated steroids: a) testosterone, b) androstenedione, 
c) epitestosterone, d) methyltestosterone, e) fluoxymesterone, f) metandienone, 
and g) (17)-epimetandienone. 
Epitestosterone (E) (Figure 5c) is an endogenous epimer of testosterone. It is 
excreted from the body mainly as glucuronide conjugate [116]. For a long time it 
was assumed to be a metabolite with no hormonal activity [121]. In recent years, 
however, the physiological role of epitestosterone has been more thoroughly revealed, 
and it is considered to have antiandrogenic activity [121, 122]. Concentrations of 
epitestosterone in plasma average 2.5 nM in men and 1.2 nM in women [121]. 
After deconjugation of glucuronide groups, the concentration of free E in urine 
is approximately 30 µg/L [118, 123]. 
The desirable anabolic effects of testosterone have encouraged the synthesis of 
over 100 testosterone-related compounds for use as drugs and doping agents [4]. 
Together these compounds are called anabolic androgenic steroids (AASs). 
Methyltestosterone (Figure 5d), fluoxymesterone (Figure 5e), and metandienone 
(Figure 5f) are commonly used AASs. AASs are employed as therapeutic agents 
in the treatment of chronic diseases such as hypogonadism, endometriosis, cancers, 
liver and renal failures, and HIV [102]. The use of testosterone, epitestosterone, and 
AASs as doping agents is prohibited by the Medical Commission of the 
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International Olympic Committee, but their use among athletes is frequently 
revealed [124]. The concentrations of T, E, and AASs in urine samples are 
determined in doping control. E is of great interest as the denominator of T/E, a 
marker of T administration [125]. The current cut-off value for T/E, set by the 
World Anti-Doping Agency, is 4 [124]. 
AASs often undergo a more concise metabolizing pathway than T [101, 126]. 
Methylation at position C-17α, for instance, blocks the metabolism of the D-ring 
(comprising 5 carbon atoms) [101]. Glucuronides are the major metabolites of most 
AASs [101]. The few exceptions include fluoxymesterone and metandienone [101]. 
After oral administration, metandienone is excreted as two unconjugated metabolites, 
namely 17-epimetandienone (Figure 5g) and 6β-hydroxy-17-epimetandienone [101]. 
2.3 Conventional techniques for the analysis of 
testosterone and related steroids 
The conventional techniques for the determination of testosterone and related 
steroids include immunoassays, GCMS, LC, and LCMS. These are briefly 
described below. 
2.3.1 Immunoassays 
Many clinical laboratories use commercial immunoassay kits to determine the 
concentration of bioavailable (non-SHBG-bound) and total testosterone in 
plasma or serum [108, 127]. Immunoassays are rapid high-throughput methods that 
take advantage of specific interactions between antibody proteins and antigens. An 
antigen must be efficiently bound by the antibody, i.e. the antibody must possess 
high affinity to the antigen. Immunoassays can be divided into those that employ 
labeled reagents and those that employ non-labeled reagents. Labels are typically 
radioactive or chemiluminescent molecules [106]. T-specific immunoassays are 
usually performed by using a competitive approach [106, 127]. The sample 
containing T is mixed with a solution containing a known amount of labeled T 
and an anti-testosterone antibody. During incubation, labeled T and T originating in 
the sample competitively bind to the antibody [106]. Testosterone concentration is 
inversely related to the amount of signal caused by the bound labeled T. 
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The analytical sensitivity of most total testosterone assays is about 0.5 nM 
(0.14 µg/L) [108], which allows reliable determination of T in healthy adult 
males [106, 108]. This sensitivity does not allow quantitative determination of T 
in women or prepubertal boys, especially if they have abnormally low levels of 
T [108, 127]. Another common problem of immunoassays [128], and especially 
of steroid assays [106, 126, 129, 130], is insufficient specificity of polyclonal 
antibodies. Polyclonal antibodies, on which most commercial immunoassays rely 
[131], often cross-react with structurally similar compounds, such as epitestosterone 
and dehydroepiandrosterone (DHEA), leading to false (too high) results in T 
determinations [106]. 
2.3.2 GCMS 
Gas chromatography- mass spectrometry (GCMS) is another established analytical 
method for testosterone and related compounds, in both clinical and doping 
control applications [106, 120, 125, 126, 132138]. GCMS is a highly sensitive 
method, providing limits of detection at the µg/L [136] and even ng/L [115] 
level for derivatized steroids. High accuracy can be obtained by using isotope-
labeled steroids as internal standards [126]. Sensitivity and selectivity can be 
improved by using GCMS/MS instrumentation. However, GCMS analyses of 
steroids require laborious sample pretreatment, including extraction (SPE or 
LLE), deconjugation of phase II metabolites, and derivatization of the polar 
hydroxyl and carbonyl groups [126, 134, 138]. Non-specific LLE and SPE 
performed, for example, with neutral polystyrene resin or stronger reversed 
phase bound silica particles [126] are not suitable for selective extraction of 
steroid molecules. Moreover, the mandatory derivatization procedures may be 
incomplete, leading to multiple derivatives of polyfunctional compounds [134]. 
2.3.3 LC and LCMS 
Liquid chromatography [123, 139142], and especially liquid chromatography
mass spectrometry (LCMS) [116, 117, 119, 135, 143149] are of growing 
interest for steroid analysis. LC and LCMS are more straightforward methods 
than GCMS since derivatization is not required [142144, 146, 149]. As in 
GCMS, improvement in selectivity and sensitivity is achieved with MS/MS 
 
40 
instrumentation [116, 118, 144148]. For example, a LOD of 1.5 ng/L is reported 
for T [147] and a LOQ of 0.5 µg/L (1.7 nM) for serum T [144]. A strong 
disadvantage of all the HPLC applications is the compulsory use of organic 
solvents, which tend to be both toxic and expensive. 
2.4 Analysis of testosterone and related steroids by 
capillary electromigration techniques 
The application of capillary electromigration techniques to the separation of 
testosterone and related compounds is a relatively new approach. Reports describing 
the separation of at least two of the compounds involved in this work are 
reviewed below. The most relevant data of these studies is compiled in Table 2. 
Note: only a few of the applications have been tested for quantitativity. 
In 1996, Fernandez et al. [20] reported a MEKC separation of liver microsomal 
testosterone products. The method was based on a complex separation medium 
consisting of 85% of 47.5 mM Tris-HCl / 2.5 mM borate / 60 mM SDS / 15 mM 
β-cyclodextrin and 15% of EtOH (v/v). Androstenedione, testosterone, and 
seven testosterone metabolites were separated in 18 min. The LOD for T was 
0.4 µM (115 µg/L). However, repeatability was relatively poor, the absolute 
inter-day RSD values for migration times and peak areas being close to 10%. 
In 1999, Kuei et al. [21] presented a brief report on the effect of three organic 
modifiers (ACN, MeOH, and 1-propanol) on the MEKC separation of seven 
steroids, including testosterone and methyltestosterone. They tested mixtures of 
10% (v/v) of an organic modifier in borate-phosphate electrolyte solutions 
containing 20 mM SDS. The use of ACN and 1-propanol in 60 mM borate-
30 mM phosphate resulted in baseline separation of all seven steroids in 17 min 
at best. The concentrations of borate and phosphate were observed to have a 
strong influence on resolution, with high concentrations (80 mM borate / 40 mM 
phosphate) leading to better resolution. The enhanced resolution at high 
concentration was explained by decrease of the EOF. Validation of the method 
was not presented. 
In 2005, Urban et al. [22] introduced a separation and in-capillary preconcentration 
method for three anabolic steroids, including T and MT. In place of SDS, they 
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used sodium taurodeoxycholate, neutral β-cyclodextrins (β-CDs), and/or anionic 
succinylated β-CDs as auxiliary components in 50 mM borate (pH 9.0). Best 
results were obtained with 10 mM succinylated β-CD and 1 mM β-CD in 50 mM 
borate devoid of surfactants. In other words, electrokinetic chromatography 
(EKC) was preferred over MEKC. The LODs for T and MT after a reverse 
migrating sample stacking process were 100 and 84 µg/L, respectively. The 
method showed good linearity for all steroid standards (r2 = 0.990 or higher). 
Recently, Silva et al. [23] investigated the separation of 11 steroids, including T 
and MT, by MEKC using EtOH, ACN, and/or tetrahydrofuran as additives in 
20 mM SDS / 20 mM tetraborate (pH 9.4). A favorable separation was obtained 
with an addition of 20% (v/v) EtOH to the pseudostationary phase. Validation of 
the method was not presented. 
A few capillary electrochromatographic (CEC) applications for testosterone and 
related steroids have been published [150, 151]. Huber et al. [150] demonstrated 
the separation of T, A, and four other steroids in 6 min by applying gradient 
elution in CEC. The silica capillary (i.d. 50 µm, Ltot/Lpacked 17.6/9.6 cm) was packed 
with Zorbax ODS particles (mean i.d. 3.5 µm), and a voltage of 14 kV was 
applied across the capillary. Another CEC approach was reported by Seifar et al. 
[151], who used silica capillaries (i.d. 50 µm, Ltot/Lpacked 32/24 cm) packed with 
even smaller porous Zorbax ODS particles (mean i.d. 1.8 µm). After the application 
of a voltage of 25 kV, separation of T, MT, and six other steroids was completed 
in 5 min. Unfortunately, validations of the CEC methods were not presented 
[150, 151]. 
During the past few years, the group of Riekkola and Wiedmer has been 
investigating the use of mobile liposomes in capillary electromigration 
techniques [152, 153], and liposome coated silica capillaries in CEC [154159]. 
T, A, and a few other steroids have been used as model compounds. The 
separations of steroids with mobile liposomes were efficient and repeatable 
(RSD of migration times 1.8%, n = 6) [152]. Separation of the same steroids in 
CEC studies was further investigated, and in one of the reports, T and A were 
separated in just 4 min [158]. However, linearity and sensitivity of these methods 
remain to be investigated to evaluate their potential in quantitative analyses. 
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Table 2. Capillary electromigration applications for testosterone and related structures. 





(nm) LOD Linearity Ref. 




n. r. [20] 
T, MT MEKC   n. r. n. r. [21] 
T, MT MEKC, EKC  245 
100 µg/L 
for T, 
84 µg/L for 
MT 
r2 = 0.990 [22] 
T, MT MEKC  247 n. r. 
r2 = 0.992 
for T, 
r2 = 0.991 
for MT 
[23] 
A, T CEC  205 n. r. n.r. [150] 
T, MT CEC  254 n. r. n.r. [151] 




245 n. r. n. r. [152], [153] 









n. r. = not reported 
2.5 Conventional sample pretreatment in the analysis of 
body fluids for testosterone and related compounds 
The presence of steroids at low concentration in complex body fluids, such as 
urine, plasma, and serum, makes sample pretreatment compulsory in all steroid 
determination procedures, excepting certain immunoassays [127]. In many 
immunoassays, release of steroids bound by SHBG is necessary [106]. Analytical 
techniques such as GCMS, LC, LCMS, and capillary electromigration techniques 
require sample pretreatment before separation, including deconjugation of the phase 
II conjugates, one or more extractions, and even derivatization (GCMS). The 
following sections describe typical hydrolysis reactions and a few representative 
non-specific extractions to give the reader an overview of these procedures. 
Derivatization is not discussed since it was not applied in the present study. 
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2.5.1 Deconjugation of phase II metabolites 
Deconjugation of the phase II metabolites of T and related structures is often 
performed as part of the sample pretreatment. The most common approach is 
enzymatic hydrolysis. The structures of the glucuronide and sulfate conjugates 






Figure 6. Structures of the glucuronide and sulfate conjugates of testosterone. 
Modified from Ref. 101. 
The juice of Helix pomatia (Hp) contains both β-glucuronidase and arylsulfatase 
activities, and has been applied, for example, in the determination of a wide 
range of anabolic steroids in bovine urine [160] and meat [161] by GCMS. 
Typically, the hydrolysis reaction with Hp is performed for several hours under 
slightly acidic conditions (pH 5.25.5) at 5255 °C [160, 161]. As a serious 
disadvantage, the juice of Hp may cause steroid conversion, for instance DHEA 
conversion to androstenedione [162] and androstenediol conversion to T [116]. 
Many sulfate conjugates are resistant to enzymatic hydrolysis, especially those 
possessing conjugates at C17 position [163]. As an alternative, they can be 
deconjugated with HCl under highly acidic conditions, but often their presence 
is simply overlooked [116]. 
The most common approach to deconjugation at present is to hydrolyze only the 
predominant glucuronide conjugates of T and related structures using 
β-glucuronidase, which usually is extracted from E. coli (Table 3). The amounts 

























currently used in doping control to determine whether or not an athlete has 
abused steroids [124]. In comparison with hydrolysis by Hp juice, time is often 
saved, and interferences present in the complex Hp juice as well as undesired 
conversion reactions are avoided. 
Table 3. Enzymatic hydrolyses of testosterone and related steroids by E. coli. 
Matrix Glucuronide conjugates pH 
Enzyme origin, 






urine T and E 6.8 
E. coli 
≥ 50 37 overnight [132] 
male 
urine T and E 7 
E. coli 




urine T and E 7.0 
E. coli 
≥ 3.3 60 1 h [135] 
male 
urine T and E 7.0 
E. coli 




urine  E 7.0 
E. coli 
> 4 60 1 h [167] 
human 
urine T and E 6.9 
E. coli 




urine  T 5.5 
Helix pomatia 
unknown 37 overnight [130] 
2.5.2 Solid-phase extraction 
Solid-phase extraction (SPE) is widely applied in the determination of steroids in 
body fluids [117, 118, 164166, 168]. Though a simple and efficient method, 
SPE suffers from poor selectivity [169] and the compulsory use of organic 
solvents (e.g. methanol [117, 118, 148], diethyl ether [164, 167], hexane / diethyl 
ether [161], or dichloromethane / ethyl acetate (4/1, v/v [146]). 
Aguilera et al. [167] applied solid-phase extraction (SPE) before enzymatic 
hydrolysis of epitestosterone glucuronides. Bond-Elut C18 cartridges were used, 
and after deconjugation the steroids were further extracted with diethyl ether by 
LLE. After evaporation of the solvent, the steroids were derivatized and 
analyzed by GCMS. 
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Recently, Rauh et al. [148] presented an in-line extraction method for A, T, and 
17α-hydroxy-progesterone combined with LCMS-MS. 100 µL of sample 
(plasma, serum, or saliva) was mixed with an internal standard solution, 
equilibrated, and exposed to protein precipitation with MeOH / zinc sulfate (50 g/L) 
(1/1, v/v) solution. The clear supernatant was injected to the HPLC system 
equipped with an extraction column (Oasis HLB®, a copolymer consisting of 
lipophilic divinylbenzene and hydrophilic N-vinylpyrrolidone). The extraction 
column was washed with an aqueous solution and then, the bound material 
including steroids was eluted from the extraction material with MeOH / ammonium 
acetate (70/30, v/v) and directed onto the analytical column. 
2.5.3 Liquidliquid extraction 
Liquidliquid extraction (LLE) is a laborious procedure that is difficult to 
automate [170]. Moreover, it often suffers from reduced recovery as compared 
with SPE [164]. As well, the use of organic solvents such as hazardous 
methylene chloride [171], dichloromethane [20, 164], or diethyl ether [118, 136, 
167] is typically required. 
Marcos et al. [139] described the determination of testosterone and 
epitestosterone in human urine by capillary LC. A sample volume of 1.0 mL was 
required. After enzymatic deconjugation of the phase II steroid metabolites, 
NaHCO3-Na2CO3 was added to the mixture and the steroids were extracted with 
n-pentane. The organic fraction was washed with KOH and evaporated to 
dryness. The residue was then reconstituted in a mixture of H2O/ MeOH 
(80/20, v/v) and analyzed by LC. 
Recently, another approach to extract T and E in human urine by LLE was 
described by Liu et al. [149]. A urine sample of 5.0 mL was required per 
analysis. After deconjugation of the glucuronide derivatives by enzymatic 
hydrolysis, the proteins were precipitated with trichloroacetic acid, and the 
supernatant was mixed with 2-propanol and K3PO4. The mixture was vortexed 
and centrifuged to facilitate phase separation, and the upper phase was analyzed 
by HPLCMS. The extraction efficiencies for T and E were 92102%. An 
advantage of Lius method is the use of 2-propanol, which is less hazardous to 
the environment than n-pentane, for instance. 
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2.6 Steroid-specific solid-phase extraction 
Conventional non-specific steroid extraction methods, discussed above, suffer 
from poor selectivity. An interesting alternative for non-specific SPE is 
immunoaffinity solid-phase extraction (IA-SPE). IA-SPE refers to those SPE 
procedures that rely on the high affinity and high selectivity of immobilized 
antibody proteins to target antigens present in a sample matrix [169]. IA-SPE 
enables selective or even specific extraction, concentration, and purification of 
analytes in complex matrices in a single step. Modern antibody engineering and 
production techniques are reviewed below, with special emphasis on studies 
involving anti-testosterone antibodies and Fab fragments. The theory of IA-SPE 
and applications for steroids are briefly presented. 
2.6.1 Antibody engineering and production techniques 
Antibodies (also called immunoglobulins) are binding proteins produced in vivo 
by B-lymphocytes. Their function is to provide specific affinity for foreign 
macromolecular substances, i.e. antigens. An intact antigen that is capable of 
activating the immune system is called an immunogen. 
Antibody-antigen complexes are typically stabilized by a variety of dipole-
dipole, van der Waals, hydrogen bond, and hydrophobic interactions. Owing to 
their specific and high affinity for antigens, antbodies have been widely used in 
analytical applications. Antibodies are able to capture antigens from highly 
complex matrices, such as body fluids, and thus they are especially useful in 
sample pretreatment procedures where eliminating interference from the sample 
matrix is desired. 
Antibodies for analytical purposes have conventionally been produced in animals by 
immunizing them with antigens. Small compounds (haptens), such as many drugs, 
are usually unable to elicit antibody production unless attached to a macromolecular 
carrier, such as BSA. Antibodies produced in an animal are polyclonal, i.e. 
structurally heterogenic, and possess different affinities and specificities for 
antigens [172]. Often they cross-react with structurally similar compounds, 
which, unless carefully compensated, may cause serious problems in analytical 
applications such as IACE [173175] and immunoassays [106, 126, 128130]. 
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Polyclonal antibodies, which contain two identical antigen binding sites, can be 
cleaved into fragments that are more suitable for analytical use. For instance, 
enzymatic digestion with papain results in two Fab fragments and one Fc 





Figure 7. Schematic view of preparation of antibody Fab and Fc fragments by 
enzymatic digestion. Modified from Ref. 85. 
Each Fab fragment contains one antigen binding site. Fab fragments are often 
preferred over whole polyclonal antibodies in analytical applications because 
differences in the pI value of polyclonal antibodies due to the variation in the 
number of sialic acids attached to the Fc region are then avoided [173]. Fab 
fragments deriving from polyclonal antibodies do not, however, solve the 
problem of cross-reactivity. 
Some 30 years ago, Köhler and Milstein [176] introduced the hybridoma 
technique, which enables the production of single monoclonal (i.e. structurally 
identical) antibodies in cell cultures. The hybridoma technique usually 
commences with the immunization of mice with one (or more) desired 
antigen(s). Subsequently, immortalization of the immune response is performed 
by hybridization of isolated mice lymphocytes with myeloma (cancer) cells. 
Typically, a few hundred hybridoma cells are cloned, some of which are likely 
to produce the desired types of antibodies [177]. 
In 1988, Parmley and Smith [178] introduced the phage display technique, 
which provides the display of antibody (fragments) on the surface of a 
bacteriophage (virus that infects bacteria, e.g. E. Coli) as a part of phages coat 
protein. Phage display allows one or a broad panel of species to be immunized, 
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and the genetic material encoding the antigen binding region of antibody 
(fragments) can be genetically engineered. Combining phage libraries prepared 
from various immunized animals leads to very large antibody libraries (up to 109 
clones), from which desired antibodies can be enriched by specific panning 
strategies [177, 179]. An example of using phase display to produce recombinant 
Fab fragments is presented by Pulli et al. [179]. An attractive feature of the 
phage display technique is that it diminishes the need for ethically problematic 
animal immunization [179]. The use of the phage display technique in clinical 
method development has been described by several groups [179181]. 
In vitro antibody engineering provides excellent tools for tailoring antibodies or 
their fragments in respect of affinity, specificity, and performance for specific 
applications [182]. In vitro production of antibody (fragment) against testosterone, 
however, is highly challenging. The binding of T to anti-T antibodies is almost 
exclusively due to shape complementarity because T is capable of participating 
in only a few hydrogen bonds [183]. Anti-T antibodies often cross-react with 
structurally similar compounds such as androstenedione, 5α-dihydrotestosterone, 
dehydroepiandrostenedione sulfate [183], and epitestosterone [184]. 
For immunoassays, the specificity of anti-T antibodies is crucial since the 
number of closely related steroid hormones in serum (and urine) is high, and 
their concentrations, usually very low, can vary significantly even among 
healthy individuals. Monoclonal antibodies able to meet the requirements of 
high affinity and specificity for measurements of T in body fluids have not been 
successfully developed by the hybridoma technique [131]. Accordingly, most 
commercial T-immunoassays rely on polyclonal antibodies. Clearly, the engineering 
of specific and effective monoclonal antibodies and antibody fragments against 
testosterone [183] and their production by the phage display technique [184] is 
of great current interest. From the point of view of analysis, compensation of the 
cross-reactivity of antibodies and their fragments by applying separation mechanisms 
capable of resolving the cross-reacting compounds, is of equal interest. 
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2.6.2 Immunoaffinity solid-phase extraction 
Ideally, a sample preparation technique should be solvent-free, simple, inexpensive, 
efficient, selective, and compatible with a wide range of separation methods [170]. 
Immunoaffinity solid-phase extraction (IA-SPE) meets many of these requirements. 
IA-SPE takes place on a support material on which antibody proteins are anchored 
(immunosorbent, IS) [169]. There are two effective procedures for immobilizing 
antibodies (and their fragments): 1) covalent binding directly to a chemically 
activated support material and 2) attachment via secondary molecules such as metal 
ions [56]. Typical reagents for sorbent activation are N,N-carbonyldiimidazole, 
cyanogen bromide, glutaraldehyde, and N-hydroxysuccinimide [185]. 
Support materials such as silica [88], activated alumina [186], controlled porous 
glass beads [84, 89], and agarose [187, 188] and other soft gels [185] have been 
reported. Porous sorbent materials allow the preparation of immunosorbents 
with high antigen capture capacity [56]. Non-specific interactions caused by 
hydrophobic or ionic forces between IS and interfering compounds in the sample 
should be avoided. The interactions generated by the sorbent itself have been 
shown to be minimal in agarose and silica-based ISs [189]. 
Antibody immobilization procedures suitable for preparing effective ISs are of 
current interest. Optimally, antibodies should be highly oriented on the sorbent 
material to provide high antigen capture capacity. Traditional antibody 
immobilization methods, such as binding via antibody amine groups provide 
random orientation, and are inefficient. As discussed below, a number of more 
sophisticated immobilization methods have been developed. 
In our recent review [86], we highlighted some of the more useful 
immobilization methods from the point of view of IACE (immobilization of 
antibodies, or their fragments, on the capillary inner wall). These methods rely 
on the formation of disulfide bonds between the cysteine groups of an antibody 
(fragment) and functional groups on the capillary wall. Especially useful is the 
method introduced by Phillips et al. [190], in which antibody Fab fragments are 
immobilized in a highly oriented way through the formation of covalent 
disulfide bridges between free thiol groups in the hinge region of the fragments 
and the maleimide-activated capillary wall. 
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Hale [191] introduced an efficient method for antibody immobilization based on 
the affinity between Co2+-iminodiacetate (IDA)-Sepharose and a histidine tag 
genetically inserted into the Fc region of an antibody. High capacity of the IS 
was obtained through optimal orientation of the antibodies. After oxidation of 
the cobalt to Co3+ under mild conditions, an irreversible complex was obtained, 
resistant to metal chelating agents, detergents, chaotropic agents, and high salt 
concentrations. After slight modifications, the protocol of Hale was successfully 
employed by Nevanen et al. [172] in developing a high-throughput enantiomer-
specific IA-SPE format based on a recombinant antibody Fab fragment. The 
high capacity and stability of the IS were again confirmed. Interestingly, not 
even a wash with 500 mM imidazole could destabilize the bonds between the 
Fab fragment and oxidized cobalt (whereas an identical wash of Cu3+-IDA-
Sepharose resulted in broken bonds between the Fab fragments and oxidized 
copper) [172]. 
The IA-SPE procedure comprises the following steps: (i) conditioning of the 
immunosorbent, (ii) percolation of the sample, (iii) washing, (iv) elution of the 
target analytes, and (v) regeneration of the immunosorbent [189]. Centrifugation, 
filtration, dilution, and modification of the pH of the sample may be necessary 
before the second (ii) step [189]. The maximum sample volume that can be 
percolated through the immunosorbent without loss of recovery, i.e. breakthrough 
volume, depends on the capacity of the IS and the affinity of the antibodies 
towards the analytes [189]. 
Elution (iv), i.e.recovery of the captured analytes, can be performed by 1) 
lowering the pH of the eluant, 2) introducing a polarity-reducing agent (such as 
methanol or ethylene glycol), or 3) applying a chaotropic agent, such as 
thiocyanate, iodide, or chloride, to disrupt the structure of water molecules 
around the antibody-antigen complex and induce complex dissociation [86]. 
Unfortunately, chaotropic agents often disturb the tertiary structure of the 
antibody in an irreversible way [192]. The most popular elution approach is to 
use an organic modifier, such as MeOH, EtOH, and ACN [188, 189]. 
Pharmaceutical and biomedical applications of in-line and off-line IA-SPE were 
reviewed by Delaunay-Bertoncini and Hennion in 2004 [189]. The hyphenation 
of IA-SPE with HPLC and CE is becoming more popular, as was discussed in 
section 2.1.4. It needs to be emphasized, however, that hyphenation of IA-SPE 
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with HPLC is easier than hyphenation with CE, especially when it comes to the 
analysis of electrically neutral analytes. 
The first hyphenated IA-SPEHPLC application for AASs, describing the 
determination of 19-nortestosterone in calf urine, was reported in 1988 [193]. 
The immunosorbent consisted of polyclonal class-specific antibodies randomly 
immobilized on CNBr-activated agarose. Two related reports, describing the 
determination of 19-nortestosterone [194] and estradiol in serum [186] by 
hyphenated IA-SPE-HPLC have appeared, both relying on randomly immobilized 
polyclonal antibodies. 
Recently, Su et al. [188] described the use of off-line multi-target IA-SPE in the 
determination of three estrogens (estradiol, estrone, and estriol) in urine of 
pregnant women samples by MEKC. The immunosorbent consisted of whole 
polyclonal anti-estrogen antibodies immobilized on CNBr-activated Sepharose. 
Antibody immobilization was based on non-specific binding via amino groups 
resulting in random orientation of the antibodies. Before IA-SPE, the urine 
samples were centrifuged for 30 min. The supernatant was then loaded onto the 
IA-SPE column, the column was washed with PBS, and the estrogens were 
eluted with MeOH / H2O (80/20, v/v). The eluted fractions were then diluted and 
analyzed by MEKC. Investigation of the stability of the IS showed that it could 
be used at least 20 times and stored at +4 °C over three months. 
Hitherto, no IA-SPE applications have been reported for testosterone, perhaps 
due to failure to produce effective anti-testosterone antibodies by the hybridoma 
technique. Specific and effective monoclonal antibodies or antibody fragments 
against testosterone are nevertheless highly desired. As discussed in section 
2.3.1, commercial immunoassays for T often suffer from cross-reactions with 
structurally similar steroids, which lead to inaccurate results. Traditional steroid 
extraction methods, such as SPE and LLE, are not specific either, and do not 
allow effective separation of T from other hydrophobic components of the sample. 
Simultaneous use of high-quality T-specific antibodies and a highly effective 
separation method for T and related steroids, hyphenated with a sensitive 
detector, should allow a more reliable determination of T in complex matrices. 
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2.7 Identification of testosterone and related compounds 
by electrospray ionization mass spectrometry 
Use of electrospray ionization mass spectrometry (ESI-MS) for the identification 
of testosterone and related steroids is of great interest due to its confirmed 
suitability for hyphenation with capillary electromigration techniques [195], 
especially capillary electrophoresis [196198], and the superior selectivity of 
MS detection. 
In electrospray ionization mass spectrometry (ESI-MS) the ions are transferred 
from solution to the gas phase, either directly by evaporation from small droplets 
near the Rayleigh limit (ion evaporation model), as suggested by Iribarne and 
Thomson [199], or through a series of coulombic fissions leading to formation of 
single gas-phase ions (charge residue model), as described by Dole et al. [200]. 
According to Kebarle [201], the ion evaporation model is more likely for small ions. 
The electrospray is a special kind of electrolytic cell, which provides an 
electrochemical conversion of ions to electrons. The difference relative to 
conventional electrolytic cells working in still solutions is that part of the ion 
transport occurs through the gas phase, where unipolar charged droplets and the 
consequent gas-phase ions are the charge carriers [202] (Figure 8). 
When the concentration of ions of one polarity at the surface of the liquid at the 
capillary tip reaches the point at which coulombic forces are sufficient to 
overcome the surface tension of the liquid, droplets enriched in one ion polarity 
are emitted from the capillary (Figure 8). To maintain the continuous loss of one 
ion polarity, the formation of opposite charge in the capillary must be neutralized. 
The charge-balancing process involves electrochemical oxidation/reduction of the 
components of the metal capillary and/or one or more species in the solution. 
This leads to an electron flow from (negative ion mode) or to (positive ion 

















































Figure 8. Formation of gas-phase ions in ESI-MS in positive ion mode. TDC is 
the total droplet current. Modified from Ref. 201. 
The most common way to hyphenate capillary electromigration techniques, 
including (PF)-MEKC, with ESI-MS is via sheath liquid [195]. The primary 
function of the sheath liquid is to provide electrical contact between the two 
instruments. An unfortunate drawback of this interfacing is the high flow rate of 
the sheath liquid, which results in diluted analyte bands and decreased sensitivity 
[195]. Sheathless CE-ESI-MS has attracted growing attention during recent 
years, but standardized designs and protocols are currently lacking [203]. 
Measured in terms of the degree to which fragmentation of the analytes occurs, 
ESI is a relatively soft ionization technique. ESI of the analytes will be adversely 
affected by the presence of other ions if these suppress analyte ionization [201]. 
Other ionization techniques, such as APCI (atmospheric pressure chemical 
ionization) [28, 42] and APPI (atmospheric pressure photoionization) [204], 
have been introduced as alternatives to ESI, but for T-related steroids, ESI offers 
slightly better sensitivity [205, 206]. 
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Identification and especially the quantification of T and related steroids by ESI-
MS are highly challenging. ESI-MS behavior of the analytes must be known 
when reliable quantification is desired. ESI-MS analysis of T-related steroids as 
their glucuronide conjugates is not simple, especially when it comes to T and E. 
The glucuronide bond to E is significantly more labile than that to T [163]. 
According to Kuuranne et al. [207], because the molecular strain in epitestosterone 
glucuronide is clearly greater than that in testosterone glucuronide, the precursor 
ion [M+H]+ of epitestosterone glucuronide in ESI-MS is significantly less stable 
than that of testosterone glucuronide. Furthermore, steroid glucuronides have a 
strong tendency to form ammonium adducts, but the extent of adduct formation 
may vary significantly [163]. After exhaustive HPLCESI-MS studies, Bowers 
and Sanaullah [163] concluded that epitestosterone glucuronide forms ammonium 
adducts to a much greater extent than testosterone glucuronide. 
Determination of free T and related steroids is less complicated than the 
determination of their glucuronide conjugates. Ma and Kim [205] investigated 
the ESI-MS behavior of 29 steroids, including T and E, by HPLCESI-MS. In 
positive ion mode, when the mobile phase consisted of MeOH / 0.1% acetic acid 
in water (80/20, v/v), both T and E produced their most stable and intense ions 
[M + H]+, 100% and 100%, and [M + Na]+, 58% and 68%, respectively. Even 
better sensitivity (between 5 and 15 pg) was obtained by single ion monitoring 
for [M + Na]+ when the presence of protons was minimized. 
Later, Leinonen at al. [206] studied the HPLCESI-MS behavior of a different 
set of steroids, including fluoxymesterone, metandienone, and MT in positive 
ion mode. Metandienone and MT produced [M + H]+ as their most intense ion 
(100%), whereas F had a stronger tendence to form [M + NH4]+. All steroids 
could be detected within 0.12.0 ng/mL. The method showed good linearity 
(r2 = 0.995) up to 250 ng/mL. 
Until now, ESI-MS has not been hyphenated with any capillary electromigration 
technique for the identification of T and related steroids. Thus, especially the use 




3. Aims of the study 
The overall objective of the study was to analyze testosterone and related 
compounds by capillary electromigration techniques making use of non-specific 
and specific interactions between steroids and additives, either mobile or 
immobilized. New methods for the determination of steroids were developed. 
Furthermore, new sample pretreatment procedures, suitable for the specific 
determination of testosterone in urine samples, were explored. 
Specifically the main aims were to: 
− develop efficient analytical methods for testosterone and structurally 
similar steroids based on micellar electrokinetic chromatography (IIV) 
and immunoaffinity capillary electrophoresis (III) 
− optimize the identification of steroids by UV spectrophotometry (IIII, V) 
and electrospray ionization mass spectrometry (I, IV) 
− develop a new immunoaffinity solid-phase extraction procedure for the 
determination of testosterone in urine samples (III) 
− study the interactions between steroids and plasma proteins by affinity 




4.1 Chemicals and materials 
The chemicals and materials used in the study are listed in Table 4. The purpose 
of each item is shortly noted. More detailed information is given in the original 
publications IV. 
Table 4. Chemicals and materials used in the study. 
Compound / material Manufacturer / Supplier Notes Publication 
Acetic acid Merck For pH adjustment I 
Androstenedione 1*, Steraloids Standard IV 
Ammonia Riedel-de Haën 25%, for pH 
adjustment 
II 
Ammonium acetate Fluka Electrolyte salt IIV 
Argon Aga Collision gas I, IV 
BCA Protein Assay Reagent Kit Pierce For colorimetric 
detection of total 
protein 
III 
Bovine serum albumin, essentially 
globulin- and fatty acid-free 
Sigma Standard V 
Bovine serum albumin, essentially 
globulin-free 
Sigma Standard V 
Chelating Sepharose Fast Flow Amersham-
Pharmacia 
Sorbent III 
Cobalt chloride hexahydrate 
(CoCl2 × 6H20) 
Merck For oriented 
immobilization of Fab 
fragments via histidine 
tag 
III 
Diethanol amine magnesium 
chloride 
Reagena ELISA reagent  
Diethyl ether Rathburn Solvent II 
17-Epimetandienone 1* Standard I 
Epitestosterone 1* Standard IIV 
Ethylenediamine tetraacetic acid 
(EDTA) 
Sigma Chelator III 
Ethanol Primalco Solvent, EOF marker  
Fluoxymesterone Steraloids Standard IIII, V 
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i.d. 50 µm, o.d. 
375 µm 
 
i.d. 5051 µm, o.d. 
360 µm 
I, III, IV 
II, V 
GelCode® Blue Stain Reagent Pierce For protein staining III 
goat anti-human Fab2 alkaline 
phosphatase 
Rockland ELISA reagent  
β-Glucuronidase from E. coli Sigma Hydrolyzing reagent, 










sulfo)cyclomaltoheptaose (HS)  




sulfo)cyclomaltoheptaose (HDMS)  
2* > 98%, electrolyte 
additive 
II 
Human serum albumin, essentially 
globulin- and fatty acid-free 
Sigma Standard V 
Human serum albumin, essentially 
globulin-free 
Sigma Standard V 
4-(2-Hydroxyethyl)-1-piperazine 
ethanesulfonic acid (HEPES) 
Sigma Electrolyte salt III 
Hydrogen peroxide Riedel-de Haën 30%, oxidizing 
reagent 
III 
Metandienone 1* Standard I 
Methanol Rathburn Solvent, EOF marker  
Methyltestosterone 1*, Steraloids Internal standard, 
standard 
IV 
MF filter Millipore 0.45 µm, biologically 
inert mixture of 
cellulose acetate and 
cellulose nitrate 
IV 
Nitrogen Aga 99.997%, nebulizing 
gas, 
drying gas 
I, II, IV 
p-Nitrophenylphosphate disodium 
salt 
Sigma ELISA reagent  
Octakis(2,3-di-O-acetyl-6-O-
sulfo)cyclomaltooctaose (ODAS)  




sulfo)cyclomaltoheptaose (OS)  




sulfo)cyclomaltooctaose (ODMS)  
2* > 98%, electrolyte 
additive, containing 





Polytetrafluoroethylene (PTFE) frit Teaninich 
Industrial Estate 
Alness 







i.d. 406 µm, for 
preparation of the  
IA-SPE cartridge 
III 
2-Propanol Rathburn Solvent IV 
Sodium chloride Riedel-de Haën For phosphate-
buffered saline (PBS) 
III 
Sodium cholate Sigma Surfactant  
Sodium dodecyl sulfate Sigma Surfactant IIV 
Sodium hydroxide Merck For capillary 
conditioning 
II 
Sodium nitrite Sigma Preservative III 
Sodium phosphate dibasic 
(Na2HPO4 × 2 H2O) 
Merck For phosphate-
buffered saline (PBS) 
III 
Sodium phosphate monobasic 
(NaH2PO4 × 2 H2O) 
J. T. Baker For phosphate-
buffered saline (PBS)  
III 
Strata X Phenomenex SPE cartridges, 30 and 
100 mg 
II, III 
Taurocholic acid, sodium salt Calbiochem Surfactant IIV 
Tauroglycocholic acid, sodium salt Merck > 65%, surfactant  
Testosterone Steraloids Standard IV 
Tris[hydroxymethyl]aminomethane Sigma Electrolyte salt V 
Testosterone-3-(O-
carboxymethyl)oxime-BSA 
Sigma ELISA reagent  
Tris[hydroxymethyl]aminomethane 
hydrochloride 
Fluka, Sigma Electrolyte salt III, V 
Tygon tubing Ismatec i.d. 380 µm, for IA-
SPE 
III 
Water Millipore Milli-Q IV 
1* A gift from United Laboratories Ltd, Helsinki, Finland (a doping laboratory accredited by WADA (World 
Anti-Doping Agency)) 




All capillary electromigration analyses in studies IV were performed with a 
P/ACE MDQ instrument (32 Karat Software, version 8.0) equipped with a 
photodiode array detector (Beckman Coulter Instruments, Fullerton, CA, USA). 
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The mass spectrometric experiments in studies I and IV were performed with a 
Quattro II triple quadrupole instrument equipped with an ESI interface 
(Micromass, Manchester, UK). 
ELISA measurements were performed with a Varioskan instrument (Thermo 
Electron). 
All pH measurements were performed with a Denver model 20 pH meter with 
combination electrode (Denver Instrument Company, CO, USA) calibrated with 
pH 4.00 (±0.01), 7.00 (±0.01), and 10.00 (±0.01) commercial buffers (Reagecon, 
Shannon, Ireland). 
Conductivity measurements were performed using a Denver model 20 pH/ 
conductivity meter with an epoxy-body conductivity cell of 0.1 cm-1 (Denver 
Instrument Co., USA). The sensor was calibrated with a conductivity standard 
solution (84 µS/cm at +25°C) (Reagecon, Shannon, Ireland). 
4.3 Methods 
The methods used in the original studies (IV) of this thesis are listed in Table 5. 
Table 5. Methods applied in the study. 
Method Publication 
PF-MEKC IIV 
UV spectrophotometry IV 
CE (CZE) II, V 
Conductivity measurements II 
Sweeping III, IV 
Direct infusion ESI-MS  I, IV 
PF-MEKCESI-MS  I, IV 
Enzymatic hydrolysis with β-glucuronidase III 




Immobilization of the Fab fragments III 
BCA Protein Assay III 
SDS-PAGE III 
Immunoaffinity solid-phase extraction (IA-SPE) III 
IACE (IA-SPEPF-MEKC) III 
PF-ACE V 
Some of the methods and protocols are briefly described in the following 
sections. More detailed information, including optimization of the methods, is 
given in the original publications IV. 
4.3.1 PF-MEKC and UV spectrophotometry 
The conditions used in the PF-MEKCUV experiments with T and related 
steroids in studies IIV are listed in Table 6. Before the analyses, the fused-silica 
capillaries were conditioned by rinsing at 20 psi (138 kPa) with 0.1 M NaOH, 
deionized water, and BGE for 1015 min. The steroids were detected at 247 nM. 
Between analyses, the capillary was rinsed for 35 min with the background 
electrolyte at 2030 psi (I, II, IV), or for 1 min with the pseudostationary phase 
and for 4 min with the BGE at 25 psi (172 kPa) (III). In all experiments, the total 
length of the capillary was 80 cm and the effective length 70 cm. All injections 
were performed by pressure. 
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29.3 mM SDS / 
1.1 mM sodium 
taurocholate / 6.7% 
(v/v) MeOH in 18.7  
mM ammonium 
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29.3 mM SDS / 
1.5 mM sodium 
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4.3.2 Capillary (zone) electrophoresis 
The migration of taurocholic acid monomers and octakis(2,3-di-O-methyl-6-O-
sulfo)cyclomaltooctaose (ODMS) was investigated in study II by CE with use of 
15 mM ammonium acetate (pH 9.5) as the background electrolyte. The operating 
voltage was +30 kV, the capillary temperature +30 °C, the detection wavelength 
195 nM, and the capillary length Ldet/Ltot 70/80 cm. The EOF marker was ethanol. 
In study V, the migration of steroids in the absence of albumin proteins was 
investigated by CE with 20 mM Tris-HCl (pH 7.8) as the BGE. The operating 
voltage was +20 kV and the capillary temperature +37 °C. 
4.3.3 Conductivity measurements 
In study II, the CMC of taurocholate was estimated by conductivity 
measurements. When the conductivity of a series of solutions with increasing 
concentrations of surfactant is measured, the specific conductivity vs. surfactant 
concentration plot shows two straight lines with different slopes. Above the 
CMC, the slope is lower [208]. The samples containing 04 mM taurocholic 
acid in 15 mM ammonium acetate (pH 9.5) were thermostated at +30 °C. 
4.3.4 Direct infusion ESI-MS 
In studies I and IV, ionization of steroids was studied by ESI-MS in positive 
ionization mode. The samples were introduced with a 1.0-mL syringe (Hamilton, 
Reno, NV, USA) by using a microsyringe pump (Harvard Apparatus, South 
Natick, MA, USA). The scan range; optimized flow rate of the drying gas (N2); 
flow rate of the nebulizing gas (N2); capillary, counter electrode (HV) lens, and 
cone voltages; the source temperature, collision energy and the pressure of the 
collision gas (Ar) applied in studies I and IV, as well as the analysis conditions, 
are compiled in Table 7. 
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Table 7. Instrumental parameters and conditions applied in the direct infusion 
ESI-MS experiments of studies I and IV. 
Parameter I IV 
scan range in MS mode (m/z,amu) 50800 50650 
scan range in MS/MS mode (m/z, amu) 20 ([M + H]+ + 20) 20320 
flow rate of sample solution (µL/min) 5 10 
flow rate of the drying gas (L/h) 250 250 
flow rate of the nebulizing gas (L/h) 1020 15 
capillary (kV), counter electrode (HV) lens (kV), 
and cone voltages (V) 
+4.0, +0.5, +40 V +3.5, +0.5, +40 V 
source temperature (°C) + 70 + 70 
collision energy (eV) in MS/MS 2030 25 
pressure of the collision gas in MS/MS (µbar) 1.7 1.7 








steroid concentration (µg/mL)  510 7.5 
4.3.5 PF-MEKCESI-MS 
PF-MEKCESI-MS of steroids was investigated in studies I and IV. The CE and 
MS instruments were connected through a commercial interface with coaxial 
sheath flow. The sheath liquid was introduced with a 1.0-mL (I) or 0.5-mL (II) 
syringe (Hamilton, Reno, NV, USA) by using a microsyringe pump (Harvard 
Apparatus, South Natick, MA, USA). The parameters (see section 4.3.2) and 
conditions applied in the PF-MEKCESI-MS studies are listed in Table 8. The 
HV lenses were removed from the ionization chamber as suggested by Vuorensola 
et al. [196]. Temperature control of the whole separation capillary was not 
possible. No drying gas was used. 
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Table 8. Parameters and conditions applied in the PF-MEKCESI-MS experiments 
of studies I and IV. 
Parameter I IV 
separation voltage (kV), back pressure (psi) +20, 0.5 +30, 0.1 
background electrolyte (BGE) 20 mM ammonium 
acetate (pH 9.5) 
20 mM ammonium 
acetate (pH 9.5) 
pseudostationary phase, 
approximate plug length 
29.3 mM SDS / 




29.5 mM SDS / 
1.5 mM sodium 
taurocholate, 
2.8 cm 
selected ions (m/z amu) in SIM 337.4, 289.3, 287.3 303.2, 289.2, 287.2 
application of TIC of the selected channels no yes 
flow rate of the sheath liquid (µL/min) 10 5 
sheath liquid composition MeOH / BGE- 
acetic acid 
(50/50/0.1%, v/v/v) 
MeOH / BGE- 
acetic acid 
(70/30/0.1%, v/v/v) 
flow rate of the nebulizing gas (L/h) 50 42.5 
capillary voltage (kV) and cone voltages (V) +3.5, +40 +3.5, +40 
source temperature (°C) 70 70 
dwell time (s) 0.08 0.08 
interchannel delay (s) 0.01 0.01 
4.3.6 Enzymatic hydrolysis of glucuronide conjugates 
Enzymatic hydrolysis of glucuronide conjugates of T was performed in study III. 
Small aliquots (0.8 mL) of male urine samples were buffered with 67 mM 
phosphate (pH 7.0) (85/15, v/v). Lyophilized β-glucuronidase from E. coli 
(≥ 1000 U) was dissolved in 1 mL of 4 mM phosphate buffer (pH 6.8). An 
aliquot of 50 U of β-glucuronidase per mL of urine was added to the samples. 
Enzymatic hydrolysis was performed at +60 °C (water bath) for 1 h. After 
hydrolysis, the samples were cooled down to room temperature. An aliquot of 
800 µL per sample was analyzed by the off-line IA-SPE and PF-MEKC as 
described in sections 4.3.1 and 4.3.9 (Table 6). 
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4.3.7 Non-specific SPE 
Analysis of steroids from spiked urine samples by PF-MEKC was investigated 
in study II. To 5-mL aliquots of male urine was added 5 µL of 100 mg/L T, A, 
and E (leading to a final concentration of 100 ng/mL for each). The spiked urines 
were purified in preconditioned (with 600 µL of methanol) and equilibrated (with 
600 µL of deionized water) Strata X (30 mg) cartridges. The impurities were 
washed out with 1.2 mL of 2% NH4OH, and the cartridges were dried for 
approximately 30 s at full vacuum. The elutions were carried out with 700 µL of 
diethyl ether, and the eluates were evaporated with a gentle stream of pure 
nitrogen (99.997%) at room temperature. Before the PF-MEKC analyses, the residues 
were dissolved in 15 mM ammonium acetate (pH 9.5) / ethanol (80:20, v/v). To 
discover the matrix effect, steroids were extracted from male urine as described 
above. The steroid-free urine percolating through the cartridges was collected. 
In study III, steroid-free female urine was used as matrix for spiked urine 
samples in order to minimize the presence of natural T. Estrogens and possible 
androgens at trace levels were removed from the female urine by SPE performed 
with Strata X (100 mg) cartridges. The cartridges were preconditioned with 
1.2 mL of methanol and equilibrated with 1.2 mL of deionized water before 
SPE. The steroid-free urine percolating through the cartridges was collected. 
4.3.8 Determation of affinity between testosterone and the 
recombinant anti-testosterone Fab fragment by ELISA 
Enzyme-linked immunosorbent assay (ELISA) was used to determine the 
affinity between testosterone (actually testosterone-3-(O-carboxymethyl)oxime-
BSA) and a recombinant anti-testosterone antibody Fab fragment, recently 
introduced by Lu et al. [184]. The Fab fragment (Fab220) was donated by Prof. 
Takkinens group. A 96-well plate was coated with 500 ng/well of testosterone-
3-(O-carboxymethyl)oxime-BSA in bicarbonate buffer (pH 9.8) for 18 h at 
+4 ºC. The plate was then washed three times with 20 mM sodium phosphate / 
150 mM NaCl (pH 7.4) (PBS). The wells were blocked with 200 µL of 0.5% 
BSA-PBS for 1 h at room temperature, and washed as described above. Fab220 
samples were prepared in 0.5% BSA-PBS. An aliquot of 100 µL of Fab220 
(100 µg/mL) and a series of Fab220 dilutions (1:100, 1:200, 1:500, 1:1000 and 
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1:1500) were pipetted on wells as duplicates (100 µL/well). The samples were 
incubated at room temperature for 2.5 h, and washed with PBS. Aliquots of 
100 µL of goat anti-human Fab2 alkaline phosphatase, diluted 1:1000 in 0.5% 
BSA-PBS, were pipetted into Fab220 wells. After 1 hour incubation at room 
temperature and a wash with PBS, the substrate (100 µL of 2 mg/mL of 
p-nitrophenylphosphate) was pipetted into each well. The absorbance was 
measured at 405 nM after 14 and 20 min. The Kd value was derived from the 
linear part of the curve (response against Fab concentration). 
4.3.9 Preparation of anti-T immunosorbent 
An anti-T immunosorbent was prepared in study III. A recombinant anti-
testosterone Fab fragment (Fab220) was immobilized on Chelating Sepharose 
Fast Flow matrix via the six-histidine tag as described by Nevanen et al. [172]. 
Chelating Sepharose (5 mL) was loaded with 12.5 mL of 200 mM CoCl2 in 
water and incubated in a rotator for 2.5 hours at room temperature. An aliquot of 
1 mL of the Co2+iminodiacetic acidSepharose was then washed with deionized 
water. An aliquot of 8.0 mL of Fab fragments (3.2 mg/mL) in 20 mM sodium 
phosphate / 150 mM NaCl (PBS, pH 7.4) was poured on the gel and incubated in 
a rotator at +4 °C for 16 h. The supernatant, as well as the following washing 
and reagent solutions, were then collected for protein determinations. The gel 
was washed with deionized water, and the cobalt was oxidized with 2 mL of 
0.03% H2O2 for 3.5 hours at room temperature. After this, the gel was washed 
with deionized water and 50 mM EDTA. After a final wash with deionized 
water, the immunosorbent was equilibrated with PBS (pH 7.4), and NaN3 was 
added as preservative to a final concentration of 0.02% (v/v). The immunosorbent 
was stored at + 4 °C before use. The supernatant, washing, and reagent solutions 
that had been in contact with the immunosorbent were analyzed to determine the 
concentration of the bound Fab fragments on the immunosorbent. Determinations 
were made by BCA Protein Assay, according to the manufacturers instructions 
(using BSA and the purified anti-testosterone Fab fragment as standards), by UV 




4.3.10 Immunoaffinity solid-phase extraction 
In study III, a microscale anti-T immunosorbent column was set up by filling a 
Tygon® tube (i.d. 380 µM, length 6.0 cm) with 5.0 µL of the immunosorbent in 
PBS (pH 7.4). The immunosorbent was held in the column by a small PTFE frit. 
IA-SPEs were performed at +23 °C. The immunosorbent was washed with 100 µL 
of 50% ethanol in 30 mM NH4OH (pH 9.5) and 100µL of 25 mM NH4OH (pH 
7.0) before use (preliminary elution) to remove the free light chains of the Fab 
fragment. The samples were manually injected to the column with a gas-tight 
1000-µL Hamilton syringe (Hamilton Bonaduz, Switzerland). After injection, 
the immunosorbent was rinsed with 100 µL of 25 mM NH4OH (pH 7.0). 
Subsequently, T was eluted with 70 µL of 50% ethanol in 30 mM NH4OH (pH 
9.5). The immunosorbent was conditioned with 100 µL of 25 mM NH4OH (pH 
7.0) before each extraction. In each stage, the fractions were collected directly in 
the CE instrument sample vials, diluted with BGE, and spiked with MT and A 
leading to a final concentration of 0.5 mg/L of external standards and 20% of 
ethanol. The samples were analyzed by the PF-MEKC method described in 
section 4.3.1 (Table 6). 
4.3.11 Hyphenated IA-SPEPF-MEKC 
In-capillary IA-SPEPF-MEKC analysis of testosterone was investigated in 
study III. Immunosorbent (0.5 µL), diluted in 20 mM Hepes (pH 7.4), was 
integrated to a commercial capillary cartridge. The background electrolyte was 
20 mM Hepes (pH 7.4). The eluant consisted of 50% ethanol in 20 mM Hepes 
(pH 7.4), and the pseudostationary phase of a ~ 13 cm long plug of 50 mM SDS 
in 20 mM Hepes (pH 7.4). The capillary containing the immunosorbent was 
equilibrated with the BGE before sample injection. The sample was hydrodynamically 
introduced to the capillary at 6.89 kPa from the outlet side for 30 s. Subsequently, the 
capillary was rinsed with the BGE at 34.5 kPa for 10 min. The eluant plug was 
injected at 68.9 kPa for 0.1 min followed by a plug of the BGE at 68.9 kPa for 
0.1 min. Finally, the pseudostationary phase was injected at 68.9 kPa for 0.45 min 
before application of +25 kV voltage. All the solutions were injected to the 
capillary from the outlet side. 
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4.3.12 Affinity measurements by PF-ACE 
In study V, the affinity between steroids and albumins (HSA, BSA) was investigated 
by partial filling ACE. The analysis conditions are compiled in Table 9. 
Table 9. Analysis conditions applied in the PF-ACE studies (publication V). 
Background electrolyte, pH 20 mM Tris-HCl, pH 7.8 
Capillary dimensions Ldet/Ltot 70/80 cm, i.d. 50 µm 
Temperature + 37 °C 
Voltage + 20 kV (250 V/cm) 
Current +8.5 µA 
Detection wavelengths  214 and 247 nM 
HSA concentration 95 µm 
BSA concentration 190 µm 
Molar ratio between HSA and a steroid 525 
Molar ratio between BSA and a steroid 1050 
 
The calculations of association constants between albumins (HSA and BSA) and 
electrically neutral steroids were based on a series of PF-ACE experiments, in 
which the total molar amount of the protein (n) introduced into the capillary was 
varied (by applying a sequence of injections for 0, 20, 40, 60, 80 and 100 s at 
3447 Pa), and the change in the migration rate of the steroids related to the 
amount of protein was monitored. The association constants, Kb, were 
















where r is the inner radius of the capillary, Ldet the effective length of the 
capillary, ta the migration time of the steroid, teof  the migration time of a neutral 
electroosmotic flow marker, t0,eof  the migration time of a neutral electroosmotic 
flow marker in the absence of protein, and n the total molar amount of protein. 
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where t0,det is the time needed for the analyte to reach the detector in the absence 
of protein, and (tdet-t0,det) is the difference between the times needed for the 
analyte to reach the detector in the presence and absence of protein. 
According to Nilsson et al. [76], the migration of a ligand in PF-ACE depends 
on the absolute amount of the injected protein in a linear way. Furthermore, the 
migration is independent of both protein mobility and protein plug length. 
Factors such as electric field strength and EOF are irrelevant if kept constant 
during the analyses.  
In our PF-ACE studies, however, EOF was needed to transfer the electrically 
neutral steroids to the detector. Thus, we could not use Eq. 11 as such. In our 
studies, the variation of EOF was compensated with use of a neutral, non-
interactive internal standard (EtOH). Instead of measuring the difference 
between the times needed for the analyte to reach the detector in the presence 
and absence of albumin, we measured the difference between the migration 
times of the analyte and EtOH in each run. The electroosmotic flow in the 




5. Results and discussion 
The use of non-specific and specific interactions in the analysis of steroids by 
capillary electromigration techniques was investigated in this work. New PF-
MEKC methods, relying on non-specific interactions between steroids, dynamic 
micelles, and cyclodextrins, were developed for quantitative determination of 
testosterone and related steroid standards. Steroid analyses by PF-MEKCUV, 
direct infusion ESI-MS, and PF-MEKCESI-MS were investigated. New 
immunoaffinity SPE applications, relying on specific interactions, either in-
capillary or off-line, between testosterone and a recombinant anti-testosterone 
Fab fragment, were tested for the determination of testosterone in male urine 
samples by PF-MEKC. Finally, interactions between steroids and albumins were 
investigated by PF-ACE. The results of the investigations are discussed below. 
5.1 Analyses of testosterone and related compounds 
by PF-MEKCUV 
The separation of testosterone and structurally related steroids by MEKC was 
the focus of the first part of the study. The partial filling (PF) approach was 
utilized from the very beginning to allow both UV and ESI-MS detection. 
Ammonium acetate was selected as the electrolyte salt in view of its volatility 
and buffering capacity in the pH range (alkaline) of interest. A relatively strong 
EOF was desired to obtain an efficient separation of the neutral steroids from the 
anionic surfactants and micelles. 
In our first experiments (I), the separation power of a pseudostationary phase 
consisting of SDS in 20 mM ammonium acetate (pH 9.5) was investigated by 
PF-MEKC where the concentration of SDS was varied between 25 and 50 mM 
and the plug length of the pseudostationary phase between 3 and 35 mM 
(corresponding to 0.45.0% of the effective capillary length). SDS is a surfactant 
possessing hydrogen-bond basicity (though lower than that of water) and 
moderate polarizability (which is determined by the difference in capacities of 
the BGE and micellar phase to interact with n- and π-electrons of the analyte) 
[209]. In our study, SDS alone did not provide separation of the structurally 
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similar steroids (fluoxymesterone, androstenedione, metandienone, testosterone, 
methyltestosterone, and 17-epimetandienone), which all have the potential to act 
as hydrogen-bond acceptors owing to one or several carbonyl group(s) and, 
except androstenedione, hydrogen-bond donors owing the one or several 
hydroxyl groups (see Figure 5 in section 2.2). The result was expected since 
earlier reports had described the insufficient separation power of SDS for 
structurally related corticosteroids [14, 15, 16]. Separation of 10 corticosteroids 
in 25 mM SDS / 25 mM borate buffer (pH 9.5) has been reported [210], but non-
volatile borate is not an optimal electrolyte for MS detection. 
We continued the PF-MEKCUV analyses with more complex pseudostationary 
phases consisting of SDS and different bile salts, namely SDSsodium cholate, 
SDSsodium tauroglycocholate, and SDSsodium taurocholate. Several different 
ratios of the SDS and bile acid concentrations were tested, as well as plug 
lengths (2842 mM) and the presence (110%, v/v) of organic additives (ACN, 
MeOH). A pseudostationary phase consisting of SDS, sodium taurocholate, and 
MeOH showed efficient resolving capacity for F, A, metandienone, T, MT, and 
17-epimetandienone. The best resolution was obtained with a 35-mm plug 
comprising 29.3 mM SDS / 1.1 mM sodium taurocholate / 6.7% (v/v) MeOH in 
BGE (I). The PF-MEKCUV data of study I is compiled in Table 10. 
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Table 10. PF-MEKCUV data of studies IIV, including limits of detection 
(S/N = 3), absolute RSD% values for peak areas and migration times, and 














I LOD (µg/L) 45  39  90  40  59  4590  - 
I RSD% (peak area) 14 12 16 11 15 13 - 
I RSD% (migration time) 0.80 0.79 0.81 0.80 0.80 0.76 - 
I Linearity (r2) 0.994 0.999 0.999 0.999 - 0.998 - 
         
II LOD (µg/L) 160  100 - 73 80 - 85 
II RSD% (peak area) 4.9 6.2 - 5.7 3.6 - 5.3 
II RSD% (migration time) 1.0 0.94 - 0.84 0.81 - 0.80 
II Linearity (r2) 0.998 0.997 - 0.999 - - 0.999 
         
III LOD (µg/L) 28 9 - 18 21 - 22 
III RSD% (peak area) 3.8 2.0 - 2.3 1.9 - 2.4 
III RSD% (migration time) 0.6 0.6 - 0.7 0.7 - 0.7 
III Linearity (r2) 0.999 0.999 - 0.999 0.999 - 0.999 
         
IV LOD (µg/L) - 65 - 97 72 - 85 
IV RSD% (peak area) - 2.2 - 1.4 2.6 - 1.4 
IV RSD% (migration time) - 0.6 - 0.5 0.5 - 0.5 
IV Linearity (r2) - 0.998 - 0.999 0.998 - 0.997 
 
The method developed in study I was highly linear (except for F) and sensitive 
in terms of LODs in comparison with results presented in earlier capillary 
electromigration reports (from 100 [22] to 115 µg/L [20] for testosterone). 
However, the absolute RSD% values for peak areas were relatively large (1116%). 
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In the following study (II), we focused on optimization of the separation of F, A, 
T, MT (i.s.), and E. Encouraged by the results obtained in study I, we first 
applied the developed method with slight variations. A good resolution was 
obtained with a 4.2-cm plug of 29.5 mM SDS / 1.5 mM sodium taurocholate in 
15.6 mM ammonium acetate with 15 mM ammonium acetate (pH 9.5) used as 
the BGE. The presence of MeOH or EtOH in the pseudostationary phase 
solution did not improve the resolution. The separation was further enhanced by 
raising the temperature and voltage from +22 °C to +30 °C, and from +25 kV to 
+30 kV. However, this method too, suffered from relatively poor repeatability. 
The absolute RSD values for migration times ranged from 1.2 to 4.6%, and those 
for peak areas from 12.7 to 15.4%. Next we investigated the effect of using 
different single-isomer sulfated cyclodextrins (HDMS, HS, HDAS, ODMS, OS, 
HDMS, Table 4) in place of sodium taurocholate in the pseudostationary phase. 
Baseline separation for F, A, T, and E was obtained with a 4.2-cm plug 
comprising 29.5 mM SDS / 20 mg/mL ODMS in 14.6 mM ammonium acetate 
(pH 9.5). This method provided better repeatability: the RSDs of the migration 
times were close to 0.9% and those of the peak areas between 5.1 and 6.6%. The 
explanation of this good result could be the more efficient removal of ODMS vs. 
taurocholate from the capillary between runs owing to weaker interactions 
between ODMS and the capillary inner wall as compared with those between 
sodium taurocholate and the inner wall. 
Finally, in study II, we investigated the PF-MEKC analysis of F, A, T, MT, and 
E utilizing the two optimized pseudostationary phases sequentally. Several 
different combinations were tested (described in detail in publication II), and the 
best results in regard to resolution were obtained by sequential injection of the 
SDS-ODMS and SDS-sodium taurocholate solutions at equal plug lengths 
(2.1 cm each) (Figure 9). RSD values for peak areas and migration times were 
close to values obtained with the SDS-ODMS mode. The results of the method 
optimized in study II are listed in Table 10 above. The sequential PF-MEKC 
proved to be less sensitive than the method optimized in study I, perhaps 
because presence of plentiful inorganic ions, including sodium and sulfate, 
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Figure 9. Separation of F, A, T, MT, and E (5 mg/L per each) by the sequential PF-
MEKC method (study II). Sample volume 8 nL. S is a system peak. Detection at 
247 nM. Detailed analysis conditions in Table 6 (page 64). 
The separation mechanism of the sequential PF-MEKC mode was carefully 
investigated. First, the function of sodium taurocholate was examined by estimating 
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Figure 10. CMC of sodium taurocholate in 15 mM ammonium acetate (pH 9.5). 
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The CMC of taurocholate in 15 mM ammonium acetate (pH 9.5) at +30 °C is 
about 2 mM. The exact value was difficult to find. The determination of CMCs 
of bile salts is in general challenging owing to their stepwise aggregation [208] 
and a low aggregation number. Earlier, CMCs for taurocholic acid of 6 mM in 
150 mM NaCl [18] and 10 mM in pure water have been suggested by Roda et al. 
[18]. In general, the CMC value of an ionic surfactant depends on the presence 
of electrolytes in the surfactant solution. All factors that lower the electrostatic 
repulsion between the charged hydrophilic head groups of ionic surfactants favor 
micelle formation [15]. Specifically, the many different aggregates of sodium 
taurocholate are stabilized by ion-ion and ion-dipole interactions, and by 
hydrogen bonds, and water and cations are essential in stabilizing the aggregates 
[211]. As compared with pure water, the repulsion between anionic taurocholate 
groups is noticeably attenuated in 15 mM ammonium acetate (pH 9.5, adjusted 
with 25% ammonia). Our low CMC value of about 2 mM is in agreement with 
the lowered repulsion. 
In our PF-MEKC studies, the presence of sodium taurocholate, even at a 
concentration (1.5 mM) under the estimated CMC (2 mM), is crucial for the 
separation in the absence of ODMS. One explanation for this could be the 
competitive solubilization between taurocholate and the analytes into the SDS 
micelles following the non-specific mechanisms described by Wiedmer at al [15]. It 
is also possible that the migration of steroids is affected by the formation of 
complexes between steroids and taurocholate monomers via hydrogen bonds. In 
the sequential PF-MEKC mode, the taurocholate monomers, injected in the 
second pseudostationary phase, penetrate the first injected pseudostationary 
phase containing SDS and ODMS. Thus, the steroid analytes are partially 
separated before they meet the second resolving component, multiply charged 
ODMS. Steroid concentration occurs at this state, possibly due to sweeping by 
ODMS. Concentration was observed as a notable increase in the peak heights, 
especially for T, as compared with those in non-sequential modes. 
The resolving power of ODMS, a derivatized γcyclodextrin, relies on its formation 
of inclusion complexes with the steroids [212]. The interactions between steroids 
and cyclodextrins are non-specific and relatively weak: association constants for 
steroids and γcyclodextrins between 2300 and 10000 M-1 have been reported 
[213, 214]. The formation of inclusion complexes is affected by temperature, 
steroid structure, and the matrix [213]. The presence of organic solvents, for 
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instance, results in lowered association constants [212, 213]. Accordingly, we 
chose not to use organic modifiers in our sequential PF-MEKC studies. 
In study III, the sequential PF-MEKC method developed in study II, was 
employed for the determination of testosterone in male urine samples. Slight 
modifications to the method were made to improve the sensitivity and 
repeatability. Sensitivity was enhanced by utilizing the micellar sweeping effect. 
A search for the largest sample injection volume yielding linear correlations 
between steroid concentrations and peak areas revealed a value of 80 nL (10-fold 
the sample volume applied in study II). Sensitivity enhancement factors in terms 
of peak heights (SEFheight) between 4.6 (for T) and 9.8 (for fluoxymesterone) were 
obtained, and the LOD values were significantly lowered as a result (Table 10). 
However, as compared with the SEFheight values reported for T in other 
conditions (1500 [24] and 330 [32]), the effect of micellar sweeping was poor. 
The reduced performance of sweeping in our study (III) is due to the high pH 
resulting in fast EOF, the presence of an organic solvent (EtOH) in the sample 
matrix (to ensure solubility of T), and the partial filling approach suffering from 
gradual decrease of micelle quantity. Repeatability of the method was improved 
by equilibrating the capillary with the pseudostationary phase solution (SDS / sodium 
taurocholate) followed by BGE between runs. The PF-MEKCUV results obtained 
in study III are compiled in Table 10, and the separation of F, A, T, MT, and E is 
























Figure 11. Separation of F, A, T, MT, and E (0.25 mg/L per each) by the 
sequential PF-MEKC method with use of sweeping (study III). Sample volume 
80 nL. S is a system peak. Detection at 247 nM. Detailed analysis conditions in 
Table 6 (page 64). 
Steroid identifications by ESI-MS and UV after similar PF-MEKC separations 
were investigated in study IV. Since the PF-MEKC method developed in studies 
II and III proved to be suitable for UV detection only (see section 5.3), a new 
PF-MEKC method without cyclodextrins, was developed. The method is similar 
to the one developed in study I (see Table 8), the most significant differences 
being the separation voltages (+ 25 kV (I) and +30 kV plus a back pressure of 
0.1 psi (IV)), the concentration of sodium taurocholate (1.1 mM (I) and 1.5 mM 
(IV)), and the pseudostationary plug lengths (3.5 cm (I) and 2.8 (IV)). The PF-
MEKCUV results of study IV are listed in Table 10. Since this PF-MEKC 
method was optimized for ESI-MS coupling in the first place, the discussion is 
continued in section 5.3. 
Relative to the few other quantitative capillary electromigration methods for T 
and related steroids (listed in Table 2, section 2.6), our optimized PF-MEKC
UV methods, especially the one developed in study III, show enhanced 
sensitivity, good repeatability, and excellent linearity. This is the first study in 
which a discontinous pseudostationary phase comprising two different solutions 
has been utilized. Interestingly, most of the analytes, including fluoxymesterone, 
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metandienone, 17-epimetandienone, and epitestosterone, have not been analyzed 
by any capillary electromigration techniques previously. 
5.2 Direct infusion ESI-MS of steroids 
Ionization of T and related steroids by ESI-MS in positive ion mode was 
investigated in studies I and IV. The data for F, A, T, MT, and E collected from 
the spectra are compiled in Table 11. Data for the ionization of metandienone 
and 17-epimetandienone are presented in publication I. 
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All the investigated steroids except 17-epimetandienone produced their most 
intense ions at m/z corresponding to [M + H]+. 17-Epimetandienone gave its 
strongest signal at m/z corresponding to [M  H20 + H]+. Protonated molecular 
ions are typically produced in ESI-MS, and also for steroids, as reported for T, 
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MT, E, and metandienone [205, 206]. In study I, the second most intense ions 
were sodium adducts, which are also often observed for steroids [205]. 
Interestingly, sodium adducts were not detected in study II. Instead, all steroids 
produced dimeric ions [2M + H]+. The explanation for these differences might 
be the greater amount of steroids injected in study IV than in study I (see Table 7) 
resulting in suppressed ionization. Ammonium adducts, earlier reported for F 
[206], were not detected in either study, despite the presence of ammonium ions 
in the sample matrices. 
In MS/MS mode, A, T, MT, and E produced fragments at m/z 97 and 109 amu. 
Such fragments are often detected in ESI-MS analyses of testosterone and 
related compounds having the 4-ene-3-one structure [206, 215, 216]. The ion at 
m/z 109 amu is formed by so-called B ring fission producing a residue of C7H9O 
[216], while the ion at m/z 97 amu represents a residue of C6H9O [216]. Some 
differences were observed in the relative abundances of these fragments, but 
they were insufficient for steroid differentiation. Importantly, the ESI-MS and 
ESI-MS/MS behaviors of testosterone and epitestosterone proved to be nearly 
identical. Fluoxymesterone did not produce any fragment ions, probably because 
the electronegative fluorine atom protected it from fragmentation. 
5.3 PF-MEKCESI-MS of steroids 
The analysis of steroids by PF-MEKCESI-MS was investigated in studies I and 
IV. 
In study I, preliminary PF-MEKCESI-MS studies for F, A, and T were 
performed using the PF-MEKC method optimized for UV detection (described 
in publication I and Table 6). Only a few modifications to the method were 
made, namely, the separation was performed at +20 kV and 3447 Pa (0.5 psi) 
back pressure. Thermosetting the separation capillary was not possible. 
The ESI-MS detection proved to be highly selective. Only the desired ions were 
detected on the selected channels ([M + H]+). Separation of the analytes was 
successful even when the separation capillary was coupled to the ESI interface. 
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In study IV, PF-MEKCESI-MS of endogenous steroids A, T, and E was 
investigated with use of MT as internal standard. The hyphenation of PF-MEKC 
and ESI-MS was optimized by first searching for the best ESI-MS conditions 
and then optimizing the PF-MEKC separation. To optimize the sensitivity of the 
ESI-MS detection, ionization of testosterone (1 µg/mL) was tested in various 
organic solvents (Figure 12). The most intense signal of [M + H]+ was detected 
in MeOH / 20 mM ammonium acetate (pH 9.5) (75/25, v/v) containing 0.1% of acetic 
acid. Almost as intense signals for testosterone were detected in EtOH / 20 mM 
ammonium acetate (pH 9.5) (75/25, v/v) and 2-propanol / 20 mM ammonium acetate 
(pH 9.5) (75/25, v/v), both containing 0.1% of acetic acid. In contrast to this, a 
relatively weak signal of [M + H]+ was detected in the ACN-based solution. Because 
methanol has a higher relative permittivity value [217], lower autoprotolysis constant 
(pKauto) [217], and lower evaporation temperature than ethanol and 2-propanol, 























Figure 12. Signal intensity of the protonated molecular ion of testosterone in 
different solutions containing organic solvent / 20 mM ammonium acetate (pH9.5) / 
acetic acid (75/25/0.1%, v/v/v) in ESI-MS (positive ion mode). 
Our starting point in study IV was the sequential PF-MEKC developed in study 
III. Unexpectedly, the method was not suitable for coupling with ESI-MS. The 
use of two different micellar solutions produced significant noise even when 
selected ion monitoring (SIM) was applied. The reason for this was not clear 
since in PF-MEKC the micelles and sulfated cyclodextrins migrate in the 
capillary slower than the electrically neutral analytes, as presented in publication 
II. One explanation could be the interference caused by the plentiful sodium ions 
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and some impurities (1% by weight sodium sulfate) in the cyclodextrin product. 
Importantly, the micellar sweeping effect could not be used as effectively in PF-
MEKCESI-MS as in the PF-MEKCUV method (discussed in section 5.1). In 
PF-MEKCESI-MS, the introduction of a sample volume of 80 nL (containing 
3200 pg of four steroids in total) caused a labile electric field across the 
capillary. A loss of current was observed when the analytes exited the capillary. 
In further studies, a new PF-MEKCESI-MS method, not relying on 
cyclodextrins, was developed and optimized. Total ion current (TIC) monitoring 
of the selected channels allowed good resolution for A, T, and E, but resolution 
between T, MT, and E was insufficient to allow their identification by TIC. 
However, all the steroids could be reliably identified through use of SIM 
analysis. The protonated molecular ions of T, MT, and E could be identified by 
SIM according to the differences in their migration times. Separation of T and E 
was crucial since their MS and MS/MS behaviors were identical (as discussed in 
section 5.2). The results were systematically compared with those obtained by 
corresponding PF-MEKCUV (Table 12). 
Table 12. Comparison of results for steroids (A, T, MT, and E) obtained by 
corresponding PF-MEKCESI-MS and PF-MEKCUV methods. 
Analyte 









Migration time (min) 6.7 8.80 7.1 9.85 7.2 10.05 7.3 10.12 
Peak width at 
50% height (min) 0.15 0.05 0.11 0.05 0.15 0.04 0.13 0.05 
LOD (µg/mL)  5 0.065 1.25 0.097 0.75 0.072 1.25 0.085 
RSD% (peak area), 
absolute 74 2.2 62 1.4 52 2.6 61 1.4 
RSD% (peak height), 
absolute 38 2.0 50 1.3 45 1.7 56 7.0 
RSD% (migration time), 
absolute 1.9 0.6 3.3 0.5 3.8 0.5 4.1 0.5 
RSD% (peak area), 
relative 42 1.7 22 3.1 - - 20 2.8 
RSD% (peak height), 
relative 30 1.8 23 1.1 - - 13 6.1 
RSD% (migration time), 
relative 0.7 0.09 0.6 0.09 - - 0.5 0.04 
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In comparison with the corresponding PF-MEKCUV method, the PF-MEKC
ESI-MS method suffered from reduced resolution, repeatability, and sensitivity. 
The elevated temperature of the separation capillary, which could not be 
thermostated in PF-MEKCESI-MS, was an important reason for the reduced 
resolution. Even though the use of an internal standard significantly enhanced 
the RSD values in PF-MEKCESI-MS, PF-MEKCUV was the more suitable 
method for quantitative analysis of steroid standards. Furthermore, in-capillary 
sample concentration by micellar sweeping could be more efficiently utilized in 
PF-MEKCUV than in PF-MEKCESI-MS. In PF-MEKCESI-MS, sweeping 
of steroids, more than 1600 pg in total, caused frequent difficulties in 
maintaining the electric field across the capillary. This is reasonable to expect 
since the electrically neutral steroid zones work as resisting medium in the 
capillary. Because the electric field in PF-MEKCESI-MS was already weakened 
by the low conductivity of the MeOH-based sheath liquid (in comparison with 
the aqueous electrolyte solution in PF-MEKCUV), and the positive voltage 
applied in the ESI needle, the PF-MEKCESI-MS field was highly sensitive to 
any disturbing factors. Furthermore, the formation of dimeric ions at high steroid 
concentrations (detected for testosterone at 7.5 µg/mL) most likely decreased the 
current. We discovered that in PF-MEKC analyses of electrically neutral steroids, 
ESI-MS interfacing sets significant limitations not only on the chemistry 
affecting the ionization and detection processes but also on the PF-MEKC 
separation itself. 
Our PF-MEKCESI-MS studies of T and related steroids are the first to consider 
the MS identification of steroids after separation by any capillary electromigration 
technique. Furthermore, limitations of sweeping in PF-MEKCESI-MS have not 
been discussed before. 
5.4 Non-specific SPE of steroids in urine samples 
Non-specific SPE of A, T, and E in spiked urine samples was performed in study 
II. The recoveries of the analytes were excellent: 105% (RSD 7.6%) for A, 92% 
(RSD 5.4%) for T, and 91% (RSD 7.6%) for E. After sequential PF-MEKC 
analysis of the spiked urine after non-specific SPE, the steroids were easily 
discriminated from the matrix. Analysis of steroid-free male urine revealed a 
non-disturbing matrix effect. 
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However, analysis of steroids (T, E) in natural male urine samples by sequential 
PF-MEKCUV method (developed in study III) after enzymatic hydrolysis with 
β-glucuronidase and non-specific SPE was not successful (unpublished data). 
Significant interference from aromatic chromophores deriving from samples 
obscured the signals of steroids. 
5.5 Analysis of the recombinant anti-testosterone Fab 
fragment and preparation of anti-T immunosorbent 
In study III, an anti-T immunosorbent was prepared to develop a new specific 
IA-SPE method for testosterone in urine. 
The recombinant anti-T Fab fragment (Fab220), kindly donated by Prof. 
Kristiina Takkinen, was analyzed by SDS-PAGE (Figure 13). 
 
Figure 13. SDS-PAGE of recombinant anti-T Fab fragment (Fab220) stained 
with Coomassie Blue under nonreducing conditions. STD is a standard solution 
of molecular weight markers, A and B are identical samples of Fab220. 
The SDS-PAGE showed that the fragment was approximately 95% pure and that 
an interchain disulfide bond was formed between the light and heavy chains. 
According to the results obtained by ELISA, the affinity between the anti-T Fab 
fragment and testosterone (actually testosterone-3-(O-carboxymethyl)oxime-
 
84 
BSA) was very high (EC50, effective concentration required to induce 50% 
response, 2.8 nM, unpublished data). Our result is in relatively good agreement 
with the EC50 value previously reported for Fab220 by Lu et al. [184] (2.8 ± 
0.3 ng/mL, i.e. 9.7 ± 1.0 nM). In comparison with the affinity reported between 
another anti-T antibody, 3-C4F5, and T (30 nM) [183], the affinity between 
Fab220 and T is about ten times higher. 
Immobilization of the Fab fragment on activated Sepharose was effective. 
Thanks to immobilization via the histidine tag, located at the heavy chain 
opposite to the testosterone binding site, the orientation of the Fab fragment was 
active. According to the absorbance measurements at 280 nM, 98.899.4% of 
the Fab fragment was coupled to Sepharose. Supporting results were obtained by 
the BCA Protein Assay and SDS-PAGE. The immobilization efficiency is in 
good agreement with that earlier reported by Nevanen et al. [9598%, 187]. The 
Fab concentration of the immunosorbent was 25 mg/mL. Theoretical binding 
capacity of the immunosorbent (0.53 nMol/µL, i.e. 150 ng/ µL) was calculated 
by assuming that the binding stoichiometry of a Fab fragment and a testosterone 
molecule is 1:1. The free light chains of the Fab fragment (~  5%) were eluted 
from the immunosorbent by preliminary elution with EtOH / 30 mM ammonium 
acetate (pH 7.4) (50/50, v/v) before extractions. 
5.6 Immunoaffinity solid-phase extraction of 
testosterone and subsequent analysis by PF-MEKCUV 
The efficiency of the IA-SPE of testosterone was determined by loading 
testosterone standards corresponding to 90% of the theoretical binding capacity 
into a 5-µL immunosorbent column as described in section 4.3.9. After elution 
with EtOH / 30 mM ammonium acetate (pH 9.5) (50/50, v/v), T was determined 
by PF-MEKCUV. The recovery of T was 90% (RSD 15.5%, n = 15), similar to 
the recovery obtained by non-specific SPE (92%, RSD 5.4%). After elution with 
EtOH / HEPES (pH 7.4) (50/50, v/v), the recovery was 92% (RSD 20.1%, n = 18). 
The IA-SPE recovery results indicate that at least 81% of the immobilized Fab 
fragments were active and able to capture one testosterone molecule each. The 
binding capacity was not decreased during repeated extraction-elution cycles 
performed in one day. The results are in good agreement with those of previous 
IA-SPE studies performed with another Fab fragment [187]. 
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Steroid-free female urine spiked with T, corresponding to 50% of the theoretical 
binding capacity of the immunosorbent, was analyzed by IA-SPE and PF-
MEKCUV. Recovery of T was excellent: 91% (RSD 12.5%). A linear correlation 
between T concentrations (35750 µg/L in steroid-free female urine) and peak 
areas was obtained with r2 of 0.989. The LOQ value for T was 35 µg/L. 
Finally, after enzymatic hydrolysis with β-glucuronidase from E. coli, three 
different male urine samples were analyzed for T. The samples were concentrated 
3.4-fold during IA-SPE. Concentration of T in urine samples varied between 
20 µg/L (RSD 20.5%) and 43 µg/L (RSD 12.1%). The results are in good agreement 
with the T concentrations in urine reported by other groups [118, 119]. 
The developed IA-SPE, based on the use of a recombinant Fab fragment 
optimally immobilized on a solid support, proved to be an efficient and fast 
sample pretreatment method for determination of T in male urine samples by 
PF-MEKCUV. In comparison with non-specific SPE, discussed in section 5.4, 
IA-SPE provided a much more effective elimination of matrix components. The 
overall analysis time, including IA-SPE and PF-MEKCUV, for a sample was 
just 14 min when the hydrolysis time (60 min) is not included. Importantly, the 
resolving power of PF-MEKCUV was beneficial in view of the minor cross-
reactivity (7.2%) reported between the anti-T Fab fragment and epitestosterone 
[184]. Although the PF-MEKCUV method (LOD 18 µg/L for T) is not as 
sensitive as immunoassays, GCMS or LCMS, the obtained LOQ enables 
determination of T in small volumes (0.81.0 mL) of male urine after IA-SPE. 
Unfortunately, the RSD values of IA-SPEs were relatively high, perhaps due to 
the manual approach that was used (see section 4.3.9). Automated extraction-
elution cycles could be expected to result in better repeatability. 
Our IA-SPE application for testosterone is the first to be described. Owing to the 
small size of the Fab fragment (~ 50 kDa) and the efficient immobilization 
method, a high concentration of active Fab fragments in the immunosorbent was 
achieved. This is an important advantage since only 5 µL of IS was required to 
prepare an appropriate IA-SPE column. In comparison with ratios used in IACE 
applications (15:1 [93] and 50:1 [98]), a low ratio of 2:1 of the Fab fragment to 
T was adequate for the quantitative capture of T from spiked urine (45 µg/L). 
Despite the stabile binding capacity of IS during one day, we preferred the use of 
fresh (unused) IS for each male urine sample to avoid interefence between samples. 
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The determination of T in male urine samples by microscale IA-SPE and 
subsequent PF-MEKCUV was clearly successful. Our method provides many 
attractive features. Compared with traditional methods for the determination of T 
in male urine it is specific (ensured by both the specific recombinant anti-T Fab 
fragment and efficient PF-MEKC), simple (no need for derivatization and 
multiple, often non-specific extraction steps) and fast. However, automation of 
the method will be required before it can be considered for routine use. 
5.7 Hyphenated IA-SPEPF-MEKCUV analysis 
of testosterone 
In study III, our original motivation was to perform in-capillary IA-SPE and 
subsequent analysis of T by PF-MEKCUV. The idea was to concentrate T 
inside the capillary prior to analysis with a view to improving the sensitivity. 
Another aim was to develop an efficient method without manual steps. The 
hyphenated application is related to IACE. Previously, IACE, based on 
immobilized antibody (fragments), has only been performed for charged ligands 
[83, 84, 8789]. We expected that thorough investigation of the chemistry and 
methodology, together with proper timing of the sample introduction, extraction, 
rinsing, elution and electromigration steps, would result in an efficient in-
capillary analysis method for a neutral ligand, too. 
Unfortunately, despite the careful optimization of the hyphenated IA-SPEPF-
MEKCUV, the method could not be stabilized, and the results were at best only 
indicative of the presence of T (standard). The challenge of the method is the 
compulsory use of surfactants, which have a destructive effect on the protein 
structures. Thus, contact between the pseudostationary phase and the immunosorbent 
has to be avoided if the method is to be repeatable. The pseudostationary phase 
had to be introduced to the capillary from the detector side, after introduction of 
the eluant plug. This resulted in great challenges to the controlled (repeatable) 
transport of solutions inside the capillary. Most likely, the construction of the 
hyphenated IA-SPEPF-MEKCUV system was not robust enough to meet 
these challenges. Further, the sequential PF-MEKCUV method, developed in 
study II, could not be employed in the hyphenated IA-SPEPF-MEKCUV 
owing to interferences by the steroid backbone of taurocholate at the steroid 
identification wavelength (247 nM). Consequently, in the hyphenated application, 
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the cross-reactivity between the Fab fragment and E [184] could not be 
effectively compensated. 
5.8 Determination of association constants between 
steroids and both human and bovine serum albumins 
In study V, an algorithm presented by Nilsson et al. [76] was modified and 
extended so as to be valid for neutral ligands, and to compensate variations in 
the EOF. Calculations of the dissociation constants, Kd, for steroids and fatty 
acid free-HSA were performed using Eq. 10 (section 4.3.11). Linear correlations 
were obtained between the molar amount of fatty acid-free HSA (n) and change 
in the steroid migration times (∆t), with r2 0.997 or higher for all steroids. The 
affinity data between the steroids and fatty acid-free HSA is compiled in Table 
13. The association constants, Kb, between HSA and testosterone, 
epitestosterone, androstenedione, methyltestosterone, and fluoxymesterone were 
32100 ± 3600 M-1, 21600 ± 1500 M-1, 13300 ± 1300 M-1, 34100 ± 200 M-1, and 
8500 ± 300 M-1, respectively. The Kb values found for testosterone and fatty 
acid-free HSA are in good agreement with the values found by other techniques 
(Kb 28000 ± 2000 M-1, log Kb 4.43 ± 0.02 at 20 ºC, obtained by equilibrium 
dialysis [112] and Kb 33000 ± 3000 M-1, log Kb 4.52 ± 0.04 at 25 ºC [114], 
obtained by equilibration reaction followed by the determination of unbound 
steroid by HPLC). The interactions between epitestosterone and HSA were 
substantially weaker than those between testosterone and HSA. This is 
interesting because T and E differ only in the spatial orientation of the hydroxyl 
group. Even weaker interactions were observed between androstenedione and 
HSA and fluoxymesterone and HSA. In contrast to this, the interactions between 
methyltestosterone and HSA were slightly stronger than those between T and 
HSA. 
We also measured the association constants between the steroids and impure 
HSA (not effectively purified from plasma fatty acids). Fatty acids have strong 
interactions with albumins (Kb values at 5 °C for example 6.7 × 107 M-1 for 
laurate and HSA, and 2.3 × 108 M-1 for myristate and HSA [218]), and the 
availability of steroids to tissues may be affected by binding of fatty acids to 
albumin [114]. Our interest was to study whether possible fatty acid residues 
present in crystallized HSA affect the binding of steroids to HSA after 
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solubilization. The affinity data between steroids and impure HSA is compiled 
in Table 13. No differences in binding of steroids to fatty acid free HSA and 
impure HSA were observed in the experiments,. Similar results have been 
reported by Watanabe and Sato [114], who observed no change in the Kb values 
for testosterone and HSA when the molar ratio of palmitic acid to HSA was 
varied between 0 and 1:1. 
Table 13. Apparent association constants, Kb, for the binding of testosterone, 
epitestosterone, androstenedione, methyltestosterone, and fluoxymesterone to 
fatty acid-free HSA and impure HSA (without fatty acids removed) at +37 °C.  
 
Similar measurements were performed for steroids and BSA (both fatty acid-free 
and impure). Linear correlations between the molar amount of fatty acid-free 
BSA and the change in the steroid migration times were excellent (r2 0.997 or 
better for all steroids). The affinity data for binding between the steroids and 
BSAs is listed in Table 14. All in all, the relative affinities between the steroids 
and BSAs were similar to those between steroids and HSA. No clear differences 
in interactions between steroids and impure BSA and between steroids and fatty 
acid-free BSA were observed. Interestingly, interactions between steroids and 
BSA were about 1.5-fold weaker than those between steroids and HSA. An 
explanation for this may be the differences in the albumin structures, assuming 
that the steroid binding sites are the same in the two proteins. 
 HSA, fatty acid-free HSA, impure 
 Kb (  M-1) log Kb Kb (  M-1) log Kb 
Testosterone 32100 ± 3600 4.50 ± 0.05 27900 ± 2100 4.45 ± 0.03 
Epitestosterone 21600 ± 1500 4.34 ± 0.04 21000 ± 700 4.32 ± 0.01 
Androstenedione 13300 ± 1300 4.12 ± 0.04 11700 ± 500 4.07 ± 0.02 
Methyltestosterone 34100 ± 200 4.53 32900 ± 2600 4.52 ± 0.04 
Fluoxymesterone 8500 ± 300 3.93 9100 ± 1700 3.95 ± 0.13 
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Table 14. Apparent association constants, Kb, for the binding of testosterone, 
epitestosterone, androstenedione, methyltestosterone, and fluoxymesterone to 
fatty acid-free BSA and impure BSA (without fatty acids removed) at +37 °C. 
 
Association constants for the binding of T-related steroids with albumins were 
little studied before this work. Except for values reported for T and HSA, and T 
and BSA [112114], association constants for binding of T-related steroids 
(androstenedione, epitestosterone, fluoxymesterone, and methyltestosterone) 
with albumins did not exist. The new data obtained here may be of considerable 
importance for endocrinologists. Particularly interesting may be the differences 
in affinities between testosterone and HSA and epitestosterone and HSA, since 
epitestosterone is considered to have antiandrogenic activity [121, 122]. The 
biological activity of a steroid (i.e. its access to receptors) is affected by 
interactions with HSA [219], and hence the weaker interactions between 
epitestosterone and HSA than between testosterone and HSA may have a 
physiological significance. 
The new algorithm developed in study V provides an easy way to determine the 
association constants for proteins and neutral ligands. It also allows the 
variations in EOF to be taken into account. Before this work, all ACE studies 
focusing on neutral ligands were based on a competitive approach [5759]. 
However, the competitive approach suffers from the common disadvantages 
associated with derivatization [82]. Furthermore, it may also suffer from 
corrupted data owing to differences in the affinities between the protein and 
small, actual (non-labeled) and labeled ligands. The new algorithm and the PF-
ACE method that were developed provide a straightforward and easy approach 
 BSA, fatty acid-free BSA, impure 
 Kb (  M-1) log Kb Kb (  M-1) log Kb 
Testosterone 18800 ± 1500 4.27 ± 0.04 20600 ± 2200 4.31 ± 0.04 
Epitestosterone 14000 ± 400 4.15 ± 0.01 14100 ± 600 4.15 ± 0.01 
Androstenedione 7800 ± 900 3.89 ± 0.06 7200 ± 400 3.86 ± 0.03 
Methyltestosterone 21100 ± 3000 4.32 ± 0.06 21700 ± 800 4.34 ± 0.01 
Fluoxymesterone 6400 ± 400 3.81 ± 0.03 8000 ± 1000 3.91 ± 0.05 
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for affinity determinations. In comparison with techniques, such as SPR and 
HPLC, PF-ACE offers significant benefits for affinity measurements, including 
easily controlled temperature and protein and ligand concentrations, and 
performance in free solution (without need for unnatural immobilization 




New efficient methods were developed for the determination of testosterone and 
related steroids. With optimized pseudostationary phases comprising surfactants 
and cyclodextrins, partial filling micellar electrokinetic chromatography 
provided an effective technique for the separation of these structurally similar 
compounds. A discontinuous pseudostationary phase, consisting of two different 
solutions, provided greater separation efficiency than the corresponding system 
where solutions were employed separately. A moderate improvement of the 
sensitivity in UV detection was obtained by micellar sweeping. 
Comparison of ESI-MS and UV detections after similar PF-MEKC separations 
showed that, in the analysis of electrically neutral steroids, UV allows higher 
sensitivity, repeatability and peak resolution. The method of analyte 
concentration by micellar sweeping could be more efficiently utilized in UV 
than in ESI-MS. Furthermore, interfacing with ESI-MS resulted in significant 
limitations not only in the chemistry affecting the ionization and detection 
processes, but in the separation itself. 
PF-MEKCUV was tested in the determination of testosterone in male urine 
samples. Enzymatic hydrolysis by β-glucuronidase from E. coli was employed in 
the deconjugation of steroid glucuronides. Non-specific SPE, performed with a 
surface-modified styrene divinylbenzene polymer, was not a suitable sample 
pretreatment method before PF-MEKCUV analysis owing to the significant 
interference from the matrix. However; a new immunoaffinity solid-phase 
extraction method, relying on specific interactions between testosterone and a 
recombinant anti-testosterone antibody Fab fragment, proved to be an excellent 
off-line pretreatment method for male urine samples before PF-MEKCUV 
analysis. After the hydrolysis and IA-SPE procedures, no further sample 
treatment was required. Previous examples of IA-SPE of testosterone do not 
exist, probably due to difficulty of producing effective anti-testosterone 
antibodies by the hybridoma technique. Here, an effective and highly specific 
Fab fragment, produced by the phage display technique, was efficiently utilized 
after immobilization in a highly oriented manner. In its specificity, simplicity, 
and rapidity, the new method (IA-SPE and subsequent analysis by PF-MEKCUV) 
for determination of testosterone in male urine provides an attractive alternative 
to traditional approaches. 
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Despite the careful optimization of the hyphenated IA-SPEPF-MEKCUV, the 
method could not be stabilized, and the results were only indicative of the 
presence of T (standard). 
Finally, new data describing the interactions of testosterone-related steroids with 
albumin proteins was obtained by PF-ACE. Notable differences in the 
association constants were found. Especially interesting were the affinity 
differences between testosterone and HSA and epitestosterone and HSA. The 
biological activity of a steroid is affected by its interactions with HSA, and 
hence the weaker interactions between epitestosterone and HSA than between 
testosterone and HSA may be of physiological significance. The new algorithm 
introduced in this study offers a straightforward method to determine the 
association constants between proteins and neutral ligands. In comparison with 
other techniques for affinity measurements, PF-ACE is more accurate and 
provides results that reflect the equilibrium as it exists in solution. 
In sum, the new capillary electromigration methods provide versatile tools for 
steroid analysis. The use of non-specific interactions between analytes and 
electrolyte additives makes possible an efficient separation and quantification of 
steroids. Finally, the use of specific interactions between steroids and 
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